<SEC-DOCUMENT>0001640334-24-001396.txt : 20240905
<SEC-HEADER>0001640334-24-001396.hdr.sgml : 20240905
<ACCEPTANCE-DATETIME>20240905101119
ACCESSION NUMBER:		0001640334-24-001396
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		18
CONFORMED PERIOD OF REPORT:	20240831
ITEM INFORMATION:		Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
ITEM INFORMATION:		Regulation FD Disclosure
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20240905
DATE AS OF CHANGE:		20240905

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			Lexaria Bioscience Corp.
		CENTRAL INDEX KEY:			0001348362
		STANDARD INDUSTRIAL CLASSIFICATION:	PHARMACEUTICAL PREPARATIONS [2834]
		ORGANIZATION NAME:           	03 Life Sciences
		IRS NUMBER:				202000871
		STATE OF INCORPORATION:			NV
		FISCAL YEAR END:			0831

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-39874
		FILM NUMBER:		241280258

	BUSINESS ADDRESS:	
		STREET 1:		100 - 740 MCCURDY ROAD
		CITY:			KELOWNA
		STATE:			A1
		ZIP:			V1X 2P7
		BUSINESS PHONE:		250-765-6424

	MAIL ADDRESS:	
		STREET 1:		100 - 740 MCCURDY ROAD
		CITY:			KELOWNA
		STATE:			A1
		ZIP:			V1X 2P7

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	LEXARIA CORP.
		DATE OF NAME CHANGE:	20080229

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	Lexaria Corp.
		DATE OF NAME CHANGE:	20051229
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>lxrp_8k.htm
<DESCRIPTION>FORM 8-K
<TEXT>
<XBRL>
<?xml version='1.0' encoding='ASCII'?>
<html xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2015-02-26" xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns="http://www.w3.org/1999/xhtml" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:iso4217="http://www.xbrl.org/2003/iso4217" xmlns:us-roles="http://fasb.org/us-roles/2024" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:lxrp="http://lxrp.com/20240831"><head><title>lxrp_8k.htm</title><!--Document Created by XBRLMaster--><meta http-equiv="Content-Type" content="text/html"/></head><body style="text-align:justify;font:10pt times new roman"><div style="display:none;text-align:justify;font:10pt times new roman;margin-left:7%;margin-right:7%;" id="XBRLDIV"><ix:header><ix:hidden><ix:nonNumeric name="dei:EntityCentralIndexKey" contextRef="From2024-08-31to2024-08-31" id="ixv-334">0001348362</ix:nonNumeric><ix:nonNumeric name="dei:AmendmentFlag" contextRef="From2024-08-31to2024-08-31" format="ixt:booleanfalse" id="ixv-335">false</ix:nonNumeric></ix:hidden><ix:references><link:schemaRef xlink:type="simple" xlink:href="lxrp-20240831.xsd"/></ix:references><ix:resources><xbrli:context id="From2024-08-31to2024-08-31"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001348362</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-31</xbrli:startDate><xbrli:endDate>2024-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-08-31to2024-08-31_lxrp_CommonStocksMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001348362</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lxrp:CommonStocksMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-31</xbrli:startDate><xbrli:endDate>2024-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:context id="From2024-08-31to2024-08-31_lxrp_WarrantsMember"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0001348362</xbrli:identifier><xbrli:segment><xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lxrp:WarrantsMember</xbrldi:explicitMember></xbrli:segment></xbrli:entity><xbrli:period><xbrli:startDate>2024-08-31</xbrli:startDate><xbrli:endDate>2024-08-31</xbrli:endDate></xbrli:period></xbrli:context><xbrli:unit id="USD"><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unit><xbrli:unit id="Shares"><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unit><xbrli:unit id="USDPShares"><xbrli:divide><xbrli:unitNumerator><xbrli:measure>iso4217:USD</xbrli:measure></xbrli:unitNumerator><xbrli:unitDenominator><xbrli:measure>xbrli:shares</xbrli:measure></xbrli:unitDenominator></xbrli:divide></xbrli:unit></ix:resources></ix:header></div><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>UNITED STATES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SECURITIES AND EXCHANGE COMMISSION</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Washington, D.C. 20549</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt">FORM <ix:nonNumeric name="dei:DocumentType" contextRef="From2024-08-31to2024-08-31" id="ixv-371">8-K</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CURRENT REPORT</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Pursuant to Section 13 OR 15(d) of the Securities Exchange Act of 1934</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Date of Report (Date of earliest event reported) <strong><span style="text-decoration:underline"><ix:nonNumeric name="dei:DocumentPeriodEndDate" contextRef="From2024-08-31to2024-08-31" format="ixt:datemonthdayyearen" id="ixv-372">August 31, 2024</ix:nonNumeric></span></strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p><table style="border-spacing:0;font-size:10pt;text-align:justify;margin-left:auto;margin-right:auto;width:60%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:74%;vertical-align:top;" colspan="6"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><span style="font-size:18pt"><ix:nonNumeric name="dei:EntityRegistrantName" contextRef="From2024-08-31to2024-08-31" id="ixv-373">LEXARIA BIOSCIENCE CORP.</ix:nonNumeric></span></strong></p></td></tr><tr style="height:15px"><td colspan="6" style="width:74%;vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Exact name of registrant as specified in its charter)</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityIncorporationStateCountryCode" contextRef="From2024-08-31to2024-08-31" format="ixt-sec:stateprovnameen" id="ixv-374">Nevada</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityFileNumber" contextRef="From2024-08-31to2024-08-31" id="ixv-375">000-52138</ix:nonNumeric></strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityTaxIdentificationNumber" contextRef="From2024-08-31to2024-08-31" id="ixv-376">20-2000871</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(State or other jurisdiction</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">of incorporation)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Commission</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">File Number)</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(IRS Employer</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">Identification&#160;No.)</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><table style="border-spacing:0;text-align:justify;font:10pt times new roman;margin-left:auto;margin-right:auto;width:85%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:45%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityAddressAddressLine1" contextRef="From2024-08-31to2024-08-31" id="ixv-377">100 &#8211; 740 McCurdy Road</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressCityOrTown" contextRef="From2024-08-31to2024-08-31" id="ixv-378">Kelowna</ix:nonNumeric>, <ix:nonNumeric name="dei:EntityAddressStateOrProvince" contextRef="From2024-08-31to2024-08-31" id="ixv-379">BC</ix:nonNumeric> <ix:nonNumeric name="dei:EntityAddressCountry" contextRef="From2024-08-31to2024-08-31" format="ixt-sec:countrynameen" id="ixv-380">Canada</ix:nonNumeric> </strong></p></td><td style="width:10%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:45%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><ix:nonNumeric name="dei:EntityAddressPostalZipCode" contextRef="From2024-08-31to2024-08-31" id="ixv-381">V1X 2P7</ix:nonNumeric></strong></p></td></tr><tr style="height:15px"><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Address of principal executive offices)</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Zip Code)</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:center;">Registrant&#8217;s telephone number, including area code<strong>&#160;<span style="text-decoration:underline">(<ix:nonNumeric name="dei:CityAreaCode" contextRef="From2024-08-31to2024-08-31" id="ixv-382">250</ix:nonNumeric>) <ix:nonNumeric name="dei:LocalPhoneNumber" contextRef="From2024-08-31to2024-08-31" id="ixv-383">765-6424</ix:nonNumeric></span></strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">_______________________________________________ </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">(Former name or former address, if changed since last report.)</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;"><ix:nonNumeric name="dei:WrittenCommunications" contextRef="From2024-08-31to2024-08-31" format="ixt-sec:boolballotbox" id="ixv-384">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160; Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:SolicitingMaterial" contextRef="From2024-08-31to2024-08-31" format="ixt-sec:boolballotbox" id="ixv-385">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160; Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:PreCommencementTenderOffer" contextRef="From2024-08-31to2024-08-31" format="ixt-sec:boolballotbox" id="ixv-386">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160; Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><ix:nonNumeric name="dei:PreCommencementIssuerTenderOffer" contextRef="From2024-08-31to2024-08-31" format="ixt-sec:boolballotbox" id="ixv-387">&#9744;</ix:nonNumeric>&#160;&#160;&#160;&#160; Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Securities registered pursuant to Section 12(b) of the Act:</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Title of each class</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Trading</strong> </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Symbol(s)</strong></p></td><td style="width:5%;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="BORDER-BOTTOM: 1px solid;width:30%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Name of each exchange on</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>which registered</strong></p></td></tr><tr style="height:15px"><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="aid_1_0" name="dei:Security12bTitle" contextRef="From2024-08-31to2024-08-31_lxrp_CommonStocksMember">Common Stock, par value $0.001 per share</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="aid_2_0" name="dei:Security12bTitle" contextRef="From2024-08-31to2024-08-31_lxrp_WarrantsMember">Warrants to Purchase Common Stock</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="aid_1_1" name="dei:TradingSymbol" contextRef="From2024-08-31to2024-08-31_lxrp_CommonStocksMember">LEXX</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><ix:nonNumeric id="aid_2_1" name="dei:TradingSymbol" contextRef="From2024-08-31to2024-08-31_lxrp_WarrantsMember">LEXXW</ix:nonNumeric></p></td><td><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">&#160;</p></td><td style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The <ix:nonNumeric id="aid_1_2" name="dei:SecurityExchangeName" contextRef="From2024-08-31to2024-08-31_lxrp_CommonStocksMember" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Capital Market</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">The <ix:nonNumeric id="aid_2_2" name="dei:SecurityExchangeName" contextRef="From2024-08-31to2024-08-31_lxrp_WarrantsMember" format="ixt-sec:exchnameen">Nasdaq</ix:nonNumeric> Capital Market</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;">Emerging growth company <ix:nonNumeric name="dei:EntityEmergingGrowthCompany" contextRef="From2024-08-31to2024-08-31" format="ixt-sec:boolballotbox" id="ixv-394">&#9744;</ix:nonNumeric></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. &#9744;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="font-size:1px;width:100%"><tbody><tr><td style="BORDER-BOTTOM: 2px solid;"/></tr><tr><td style="BORDER-BOTTOM: 5px solid;"/></tr></tbody></table><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="TEXT-INDENT: 0px;"/></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Item 5.02</strong> <strong>Departure of Directors or Certain Officers; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On August 31, 2024, pursuant to the approval of its Board of Directors (&#8220;Board&#8221;), Lexaria Bioscience Corp. (the &#8220;Company&#8221;) appointed Richard Christopher, age 54, to the position of Chief Executive Officer replacing Christopher Bunka who will remain as the Company&#8217;s Chairman of the Board and as a strategic advisor to the executive team.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In connection with Mr. Bunka&#8217;s transition to a consulting role, the Company paid the following as a severance package to terminate the current independent contractor agreement (the &#8220;Contract&#8221;) for CEO services (the Contract being previously filed with the Company&#8217;s 10-Q on January 14, 2022):</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;text-align:justify;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td style="width:4%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="width:4%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">A lump sum Termination Break Fee equal to 17 times the current Monthly Fee (such capitalized terms as defined in the Contract);</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">A pro rata portion of any Annual Bonus (as that term is defined in the Contract) payable pursuant to the completion of performance milestones; and</td></tr><tr style="height:15px"><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><span style="font-family:symbol">&#183;</span></p></td><td style="vertical-align:top;">Any Material Transaction Bonus that may be payable within six (6) months of the termination date.</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Mr. Christopher who will be the Company&#8217;s ongoing CEO, will also be assuming the responsibilities of principal financial officer and principal accounting officer until the Company has appointed a new Chief Financial Officer.&#160; Mr. Christopher does not have any family relationships with any other person employed or engaged by the Company nor has Mr. Christopher been a party to any transaction with the Company exceeding $120,000.&#160; </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Mr. Christopher has extensive experience with pharmaceutical and medical device companies.&#160; He was the Chief Financial Officer of Invivo Therapeutics Holdings Corp. (&#8220;InVivo&#8221;) from 2019 to 2024.&#160; InVivo Therapeutics was a pioneering biomaterials and biotechnology company with a focus on the treatment of spinal cord injuries. Its goal was to develop and commercialize groundbreaking technologies and treatments for spinal cord injury (SCI). At the core of InVivo&#8217;s technology portfolio was the Neuro-Spinal Scaffold&#8482; a novel and proprietary biomaterial that is implanted into the epicenter of the injury to modulate the healing environment and serve as a support for neuroregeneration. As the Neuro-Spinal Scaffold failed to advance through clinical trials, InVivo delisted from the Nasdaq Stock Market around March 20, 2024.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Mr.&#160;Christopher was the Chief Financial Officer of iCAD,&#160;Inc.&#160;from December&#160;2016 through January&#160;2019. &#160;iCAD,&#160;Inc. is a Nasdaq-listed company with a focus on therapies and solutions for the early identification and treatment of cancer, where he held both financial and operational responsibilities. &#160;Prior to iCAD,&#160;Inc., Mr.&#160;Christopher was Chief Financial Officer from March&#160;2014 through December&#160;2016 and Chief Operating Officer from October&#160;2015 through December&#160;2016 of Caliber Imaging&#160;&amp; Diagnostics,&#160;Inc., a medical technology company focused on cancer detection imaging solutions, with primary applications in dermatology. Prior to Caliber and starting in 2000, Mr.&#160;Christopher held various positions of increasing responsibility at DUSA Pharmaceuticals,&#160;Inc., a Nasdaq-listed dermatology company focused on the treatment of precancerous skin lesions, where he ultimately served as Chief Financial Officer from January&#160;2005 through its acquisition and integration into Sun Pharmaceuticals Industries Ltd in April&#160;2013.&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Mr.&#160;Christopher holds a Master of Science in Accounting from Suffolk University and a Bachelor of Science in Finance from Bentley University.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In connection with his employment with the Company and pursuant to the terms of an employment agreement dated August 31, 2024, (the &#8220;Agreement&#8221;),&#160;Mr.&#160;Christopher will receive an annual Base Salary which shall be increased by 5% on each of January 1, 2025 and 2026. &#160;Mr.&#160;Christopher is also eligible for an annual bonus that targets fifty percent (50%)&#160;of his annualized Base Salary based upon achievement of certain performance goals. &#160;In accordance with the Agreement, on Augst 31, 2024, the Board granted Mr.&#160;Christopher an incentive stock option to purchase up to 200,000 shares of the Company&#8217;s common stock, pursuant to its Equity Incentive Plan (the &#8220;Options&#8221;). The Options have an exercise price per share equal to $3.92, &#160;being one cent ($0.01) above the closing price of the Company&#8217;s shares on the Nasdaq Capital Market &#160;closest to the grant date, and will vest commencing on February 28, 2025 as to 50,000 options with the balance being vested monthly from March 31, 2025 to November 30, 2026 as to 6,818 options with the balance of 6,822 options vesting on December 31, 2026.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">2</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Mr. Christopher is also entitled to a material transaction bonus if a change of control of the Company occurs, or within six months of termination without Just Cause or for Good Reason, equal to twelve (12) months of Base Salary if a Change of Control occurs during the first year of the Term, thirteen (13) months of Base Salary if a Change of Control occurs in the second year of the Term and fourteen (14) months of Base Salary if a Change of Control occurs in the third year of the Term or any subsequent year of the Term.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Mr.&#160;Christopher is also entitled to severance payments under the Employment Agreement. If his employment is terminated by the Company without Just Cause or by him for Good Reason, he shall receive one (1) month of Base Salary for each one (1) month of employment the Executive has completed with LBC up to a maximum of twelve (12) months&#8217; Base Salary in addition to any accrued wages and earned bonus. </p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">The description of Mr. Christopher&#8217;s compensation is qualified in its entirety by the agreement that will be filed as an exhibit to the Company&#8217;s annual 10-K Periodic Report.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>Item 7.01</strong>&#160;<strong>Regulation FD Disclosure</strong>&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Christopher Bunka, the outgoing Chief Executive Officer of Lexaria Bioscience Corp. (&#8220;Lexaria&#8221;) has issued his final letter providing Lexaria&#8217;s strategic update.&#160; A copy of the letter is attached as Exhibit 99.1.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">In accordance with General Instruction B.2 of Form 8-K, the information contained in Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed &#8220;filed&#8221; for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended, or otherwise subject to the liabilities of that section. The information in item 7.01 and Exhibit 99.1 of this Current Report on Form 8-K shall not be incorporated by reference into any filing or other document pursuant to the Securities Act of 1933, as amended, except as shall be expressly set forth by specific reference in such filing or document.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in"><strong>Item 9.01 </strong><strong>Financial Statements and Exhibits</strong></p><p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px;background-color:#cceeff"><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="lxrp_ex991.htm">99.1</a></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><a href="lxrp_ex991.htm">Letter from the CEO</a></p></td></tr><tr style="height:15px;background-color:#ffffff"><td style="width:9%;vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">104</p></td><td style="width:2%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px">Cover Page Interactive Data File (embedded within the Inline XBRL document).</p></td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">3</p></td></tr><tr style="height:15px"><td><p style="page-break-after: always"></p></td></tr><tr style="height:15px"><td>&#160;</td></tr></tbody></table><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SIGNATURES</strong></p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.</p><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font-size:10pt;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td colspan="2" style="vertical-align:top;"><p style="font-size:10pt;font-family:times new roman;margin:0px"><strong>LEXARIA BIOSCIENCE </strong><strong>CORP.</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="2"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: 1px solid;vertical-align:bottom;" colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><em>/s/ John Docherty</em></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>John Docherty</strong></p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="2" style="vertical-align:top;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">President</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td colspan="2"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></td><td><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr><tr style="height:15px"><td style="width:4%;vertical-align:bottom;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Date:</p></td><td style="width:31%;vertical-align:bottom;"><p style="font-size:10pt;font-family:times new roman;margin:0px">September 5, 2024</p></td><td style="width:65%;"><p style="font-size:10pt;font-family:times new roman;margin:0px">&#160;</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p><table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"><tbody><tr style="height:15px"><td class="hpbhr">&#160;</td></tr><tr style="height:15px"><td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;">4</p></td></tr></tbody></table><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&#160;</p></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>lxrp_ex991.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head><title>lxrp_ex991.htm</title><!--Document created using EDGARMaster--></head><body style="TEXT-ALIGN: justify; FONT: 10pt times new roman; MARGIN-LEFT: 7%; MARGIN-RIGHT: 7%"><p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:right;"><strong>EXHIBIT 99.1</strong></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="lxrp_ex991img2.jpg"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><font style="font-size:14pt">Lexaria Releases Strategic Letter from the Outgoing CEO</font></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>Kelowna, British Columbia &#8211; September 5, 2024</strong> &#8211; Lexaria Bioscience Corp. (Nasdaq: LEXX, LEXXW) (the &#8220;Company&#8221; or &#8220;Lexaria&#8221;), a global innovator in drug delivery platforms is pleased to provide this letter from outgoing Chief Executive Officer (&#8220;CEO&#8221;) Chris Bunka as a strategic update to all stakeholders.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong><font style="font-size:14pt">CEO LETTER TO STAKEHOLDERS</font></strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">It is with mixed emotions and a heavy heart that I write my final strategic letter to my Lexaria family. Lexaria has been &#8220;home&#8221; for 16 years, and, similar to raising a family, there have been difficult times that test your resolve, and many other times of incredible joy and pride.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Many people will focus on the &#8220;why&#8221;. There is just one, fairly simple reason: Lexaria has arrived! We have finally found a sector that desperately needs our technology and we are pursuing our commercial opportunities vigorously; this includes our recently announced entrance into a Material Transfer Agreement with a pharmaceutical company. With our clear new focus, the need to pivot &#8211; one of my particular skillsets &#8211; is no longer necessary. Lexaria is now focused on pharmaceutical studies in the cardiometabolic and GLP-1 sectors; on operations; and, on expected industry collaborations.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Given the new focus, we need a steely-eyed CEO with years of pharma/biotech operations experience &#8211; something I do not possess. Under most of my tenure our strategy was one of <em>exploration</em>. Our strategy today has evolved to one of <em>execution</em>. Today we are well known to the investment banking and investor communities, and we are increasingly known to the pharmaceutical industry. Our immediate tasks are no longer primarily focused on discovery &#8211; today we focus on execution. Our new CEO, Richard Christopher, has years of experience running operations and facilities, dealing with the FDA and other regulators, and loads of public market and financing experience. He also has the &#8220;fire in the belly&#8221; that cannot be taught.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lexaria has graduated! It is time for our exciting new chapters to unfold.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>CAPITAL MARKETS and SHAREHOLDERS</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We&#8217;ve had a truly exciting first eight months of 2024!</p> <table style="border-spacing:0;text-align:justify;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td style="width:4%;"> <p style="margin:0px">&nbsp;</p></td> <td style="width:4%;vertical-align:top;"> <p style="margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">We filed our IND with the FDA and received our clearance letter to proceed with our Phase 1b hypertension study. Subject to financing, that study is likely to begin in 2025.</td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">We&#8217;ve raised over $8.5 million during 2024, through equity raises and warrant exercises.</td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">We launched multiple studies in GLP-1 and have recently started reporting results.</td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td style="vertical-align:top;"> <p style="margin:0px"><font style="font-family:symbol">&#183;</font></p></td> <td style="vertical-align:top;">Our market capitalization has grown from roughly $5 million in June of 2023 to approximately $60 million today.</td></tr> <tr style="height:15px"> <td> <p style="margin:0px">&nbsp;</p></td> <td> <p style="margin:0px;text-indent:30px">&nbsp;</p></td> <td> <p style="margin:0px">&nbsp;</p></td></tr></table> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="lxrp_ex991img2.jpg">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><img src="lxrp_ex991img3.jpg"></p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><em>LEXX stock price (daily bars) vs. XBI biotech Index (solid blue line)</em></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lexaria has experienced strong trading volume relative to our still-small share capital structure, and we have many new shareholders since we&#8217;ve announced our focus on the GLP-1 sector. I&#8217;m confident that we have the strongest and smartest shareholder base ever. It has been my pleasure to serve you during my tenure, and many of you know that I have always placed you first. I truly believe that Lexaria&#8217;s new CEO, Richard Christopher, will be able to serve your needs during this next exciting phase of our growth, better than I.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Shorters and distorters are an unfortunate part of the market environment and roughly equally as useful as buzzards &#8211; they serve a purpose and feed off of emotional reactivity. But to all of you, I would say; never believe anything you read on chat boards - the entire concept of anonymous posting begs for abuse. For our thousands of shareholders, be sure you get your news directly from the Company and from our regulatory filings. I encourage everyone to phone or email George Jurcic &#8220;our internal IR guy&#8221; if you need explanations or require additional information (contact information below).</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>Phase 1 Studies</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">On March 1, 2024, we received clearance from the FDA for our Phase 1b hypertension trial utilizing DehydraTECH-CBD (&#8220;<strong>DHT-CBD</strong>&#8221;). Since then, we have been busy complying with other FDA requests for additional information; have made some design changes to the study and are also obtaining fresh quotes from service providers to conduct the study. We will be opportunistic in raising additional funds that will be required to launch that study, as well as to manufacture fresh DHT-CBD test articles as we get closer to a launch date. While we still do not have any firm dates, it seems highly likely that this registered trial may begin in the first half of 2025.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="lxrp_ex991img2.jpg">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We meanwhile have created a new wholly-owned Australian subsidiary which has been very aggressive with our GLP-1 study investigations, and with our CRO, is currently working on our Australian-registered Phase 1b DehydraTECH-GLP-1 diabetes and weight-loss study to be conducted over 12 weeks of dosing. We have sufficient funds on hand to conduct this study. We are preparing for manufacturing of the drug product which should be completed within 100 days. Clinical site investigations are ongoing and Lexaria will have a more fulsome update on the progress of this study, soon.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">So, it appears we are likely to have TWO Phase 1 studies running in 2025: quite an achievement for a company with a ~$60 million valuation; and a smart way to strategically diversify.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>R&amp;D</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lexaria has been generating a lot of data from our ongoing GLP-1 studies, and the Company expects to do so for most of the rest of 2024 and 2025. I&#8217;m not intending to update each study here: review our recent press releases for more detailed information and watch for more upcoming news.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">A couple of general points: Lexaria never expected to report double-digit percentage weight loss numbers from our current rodent study. If any of you had that expectation, I&#8217;m sorry to inform you that isn&#8217;t realistic. Rodents will often eat themselves to a morbid state if given the opportunity to do so with <em>unlimited food</em> such as we offered during our ongoing rodent study. In this type of study, simply not gaining any additional weight can be considered something of a win.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Instead, we hoped the data would guide us in other pursuits such as deciding on formulations for our upcoming 12-week human study. It also is helpful to our imminent decisions to design and execute additional human pilot study work, and additional directional animal work. Stay tuned!</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">We have incredibly positive results accumulating utilizing DHT-CBD, and in our current animal study we have one specialized DHT-CBD formulation outperforming in weight loss applications, and another DHT-CBD formulation outperforming in blood sugar control. This is unexpectedly bountiful and strongly affirms our prior years of research and investigation into DHT-CBD.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As all you athletes know, you train and prepare for success by <em>focusing</em> on success &#8211; you repeat those things that deliver results. Lexaria is the same: we follow our successful data and look for ways to build commercial success from positive R&amp;D data. I firmly believe that our recent success in GLP-1 R&amp;D is going to manifest into commercial success in 2025. And yes, I&#8217;m aware that my earlier timelines have sometimes been too aggressive &#8211; but I&#8217;m also aware of the ripples that our recent work has created within the pharma industry leading, for example, to our recently announced Material Transfer Agreement with a pharmaceutical company. We are focused on success and will not rest until we have achieved both R&amp;D <em>and</em> commercial success.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="lxrp_ex991img2.jpg">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:center;"><strong>SUMMARY</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Lexaria is enjoying considerable success in our GLP-1 R&amp;D program, with results already demonstrating interesting areas of superiority including DehydraTECH-processed oral semaglutide and liraglutide, as well as DHT-CBD. The Company has also made great progress with its DHT-CBD in the hypertension space as an area of great promise for expanded registered clinical testing expected through 2025. Lexaria has stated publicly that we&#8217;ve caught the attention of &#8220;Big Pharma&#8221; and our ongoing discussions and relationships could provide for increased activity in the months and quarters to come.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">It is <em>because</em> of the combination of events that include our successful money-raising, our R&amp;D success, our new relationship with one pharmaceutical company and continued pursuit of others, and our confidence in our strategic direction for the foreseeable future, that I am using the opportunity to replace myself with someone with stronger skillsets than my own, in corporate operational areas that we&#8217;ve identified as necessary for our commercial success.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Indeed, it is my high level of confidence that commercial success is in our path, that endows me with the certainty to step aside for new leadership at Lexaria. I literally would work myself to death at Lexaria if I lacked that confidence &#8211; I can make no stronger a statement in my level of comfort in Lexaria than turning over the helm to a younger, more experienced executive ideally suited for the Company&#8217;s evolution.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">As I said in January, &#8220;<em>I have been a shareholder of Lexaria for a very long time: I know how our shareholders feel as you watch our progress because I feel most of the same things you do. I&#8217;ve always tried to be straight-up with you even as we&#8217;ve juggled some daunting challenges. We have new shareholders&#8230; who have enthusiastically supported our most recent corporate strategies &#8211; to you I offer a special &#8220;thank you&#8221; for your support.&#8221;</em></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">It is my honour to be part of Lexaria&#8217;s past as well as contribute to its very bright future.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px 0px 0px 0in">Chris Bunka</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Mr. Bunka has been appointed as Executive Strategic Advisor to the management team where he will continue to provide support and advice to Lexaria. He also remains as Chairman of the Board of Directors of Lexaria and looks forward to providing more focused strategic leadership in that role.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>About Lexaria Bioscience Corp.</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">Lexaria Bioscience Corp.&#8217;s patented drug delivery technology, DehydraTECH&#8482;, improves the way active pharmaceutical ingredients (APIs) enter the bloodstream by promoting more effective oral delivery. Since 2016, DehydraTECH has repeatedly demonstrated the ability to increase bio-absorption with cannabinoids, antiviral drugs, GLP-1 and more. DehydraTECH has also evidenced an ability to deliver some drugs more effectively across the blood brain barrier. Lexaria operates a licensed in-house research laboratory and holds a robust intellectual property portfolio with 46 patents granted and many patents pending worldwide. For more information, please visit www.lexariabioscience.com.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px 0px 0px 0in; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr> <tr style="height:15px"> <td><p style='page-break-after: always'></p></td></tr> <tr style="height:15px"> <td>&nbsp;</td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px"><img src="lxrp_ex991img2.jpg">&nbsp;</p> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>CAUTION REGARDING FORWARD-LOOKING STATEMENTS</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">This press release includes forward-looking statements. Statements as such term is defined under applicable securities laws. These statements may be identified by words such as "anticipate," "if," "believe," "plan," "estimate," "expect," "intend," "may," "could," "should," "will," and other similar expressions. Such forward-looking statements in this press release include, but are not limited to, statements by the Company relating to the Company&#8217;s ability to carry out research initiatives, receive regulatory approvals or grants or experience positive effects or results from any research or study. Such forward-looking statements are estimates reflecting the Company's best judgment based upon current information and involve a number of risks and uncertainties, and there can be no assurance that the Company will actually achieve the plans, intentions, or expectations disclosed in these forward-looking statements. As such, you should not place undue reliance on these forward-looking statements. Factors which could cause actual results to differ materially from those estimated by the Company include, but are not limited to, government regulation and regulatory approvals, managing and maintaining growth, the effect of adverse publicity, litigation, competition, scientific discovery, the patent application and approval process, potential adverse effects arising from the testing or use of products utilizing the DehydraTECH technology, the Company&#8217;s ability to maintain existing collaborations and realize the benefits thereof, delays or cancellations of planned R&amp;D that could occur related to pandemics or for other reasons, and other factors which may be identified from time to time in the Company's public announcements and periodic filings with the US Securities and Exchange Commission on EDGAR. The Company provides links to third-party websites only as a courtesy to readers and disclaims any responsibility for the thoroughness, accuracy or timeliness of information at third-party websites. There is no assurance that any of Lexaria&#8217;s postulated uses, benefits, or advantages for the patented and patent-pending technology will in fact be realized in any manner or in any part. No statement herein has been evaluated by the Food and Drug Administration (FDA). Lexaria-associated products are not intended to diagnose, treat, cure or prevent any disease. Any forward-looking statements contained in this release speak only as of the date hereof, and the Company expressly disclaims any obligation to update any forward-looking statements or links to third-party websites contained herein, whether as a result of any new information, future events, changed circumstances or otherwise, except as otherwise required by law.</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>INVESTOR CONTACT:</strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;"><strong>George Jurcic - Head of Investor Relations</strong><strong> </strong></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">ir@lexariabioscience.com</a></p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">Phone: 250-765-6424, ext 202</p> <p style="FONT-SIZE: 10pt; FONT-FAMILY: times new roman; MARGIN: 0px; text-align:justify;">&nbsp;</p> <table style="border-spacing:0;font:10pt times new roman;width:100%" cellpadding="0"> <tr style="height:15px"> <td class="hpbhr">&nbsp;</td></tr> <tr style="height:15px"> <td style="BORDER-BOTTOM: black 1px solid; TEXT-INDENT: 0px;"></td></tr></table> <p style="font-size:10pt;font-family:times new roman;margin:0px">&nbsp;</p><body>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>3
<FILENAME>lxrp-20240831.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 08/30/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<schema xmlns:xl="http://www.xbrl.org/2003/XLink" xmlns:ref="http://www.xbrl.org/2006/ref" xmlns:currency="http://xbrl.sec.gov/currency/2024" xmlns:us-gaap-att="http://fasb.org/us-gaap/attributes" xmlns:sic="http://xbrl.sec.gov/sic/2024" xmlns:exch="http://xbrl.sec.gov/exch/2024" xmlns:invest="http://xbrl.sec.gov/invest/2013-01-31" xmlns:negated="http://www.xbrl.org/2009/role/negated" xmlns:naics="http://xbrl.sec.gov/naics/2024" xmlns:us-types="http://fasb.org/us-types/2024" xmlns:stpr="http://xbrl.sec.gov/stpr/2024" xmlns="http://www.w3.org/2001/XMLSchema" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xmlns:xbrldi="http://xbrl.org/2006/xbrldi" xmlns:country="http://xbrl.sec.gov/country/2024" xmlns:utr="http://www.xbrl.org/2009/utr" xmlns:srt-types="http://fasb.org/srt-types/2024" xmlns:dtr-types="http://www.xbrl.org/dtr/type/2020-01-21" xmlns:srt-roles="http://fasb.org/srt-roles/2024" xmlns:dei="http://xbrl.sec.gov/dei/2024" xmlns:num="http://www.xbrl.org/dtr/type/numeric" xmlns:nonnum="http://www.xbrl.org/dtr/type/non-numeric" xmlns:srt="http://fasb.org/srt/2024" xmlns:us-gaap="http://fasb.org/us-gaap/2024" xmlns:lxrp="http://lxrp.com/20240831" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://lxrp.com/20240831">
  <annotation>
    <appinfo>
      <link:roleType roleURI="http://lxrp.com/role/Cover" id="Cover">
        <link:definition>000001 - Document - Cover</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
      <link:linkbaseRef xlink:type="simple" xlink:href="lxrp-20240831_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="lxrp-20240831_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="lxrp-20240831_cal.xml" xlink:role="http://www.xbrl.org/2003/role/calculationLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
      <link:linkbaseRef xlink:type="simple" xlink:href="lxrp-20240831_def.xml" xlink:role="http://www.xbrl.org/2003/role/definitionLinkbaseRef" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" />
    </appinfo>
  </annotation>
  <import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd" />
  <import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd" />
  <import namespace="http://xbrl.org/2005/xbrldt" schemaLocation="http://www.xbrl.org/2005/xbrldt-2005.xsd" />
  <import namespace="http://xbrl.sec.gov/country/2024" schemaLocation="https://xbrl.sec.gov/country/2024/country-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/currency/2024" schemaLocation="https://xbrl.sec.gov/currency/2024/currency-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/dei/2024" schemaLocation="https://xbrl.sec.gov/dei/2024/dei-2024.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/non-numeric" schemaLocation="http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/numeric" schemaLocation="http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd" />
  <import namespace="http://xbrl.sec.gov/exch/2024" schemaLocation="https://xbrl.sec.gov/exch/2024/exch-2024.xsd" />
  <import namespace="http://www.xbrl.org/2009/arcrole/fact-explanatoryFact" schemaLocation="http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/negated" schemaLocation="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd" />
  <import namespace="http://www.xbrl.org/2009/role/net" schemaLocation="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd" />
  <import namespace="http://xbrl.sec.gov/naics/2024" schemaLocation="https://xbrl.sec.gov/naics/2024/naics-2024.xsd" />
  <import namespace="http://xbrl.sec.gov/sic/2024" schemaLocation="https://xbrl.sec.gov/sic/2024/sic-2024.xsd" />
  <import namespace="http://fasb.org/srt-roles/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd" />
  <import namespace="http://fasb.org/srt-types/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd" />
  <import namespace="http://www.xbrl.org/dtr/type/2020-01-21" schemaLocation="https://www.xbrl.org/dtr/type/2020-01-21/types.xsd" />
  <import namespace="http://xbrl.sec.gov/stpr/2024" schemaLocation="https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd" />
  <import namespace="http://fasb.org/us-roles/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd" />
  <import namespace="http://fasb.org/us-types/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd" />
  <import namespace="http://fasb.org/srt/2024" schemaLocation="https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd" />
  <import namespace="http://fasb.org/us-gaap/2024" schemaLocation="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd" />
  <element name="CommonStocksMember" id="lxrp_CommonStocksMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
  <element name="WarrantsMember" id="lxrp_WarrantsMember" nillable="true" xbrli:periodType="duration" type="nonnum:domainItemType" substitutionGroup="xbrli:item" />
</schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>4
<FILENAME>lxrp-20240831_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 08/30/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel" roleURI="http://www.xbrl.org/2009/role/negatedLabel" />
  <link:roleRef xlink:type="simple" roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel" roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel" roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel" roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel" roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" />
  <link:roleRef xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel" roleURI="http://www.xbrl.org/2009/role/netLabel" />
  <link:labelLink xlink:type="extended" xlink:role="http://www.xbrl.org/2003/role/link">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="dei_CoverAbstract" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CoverAbstract" xlink:to="dei_CoverAbstract_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CoverAbstract_lbl" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="dei_EntityRegistrantName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityRegistrantName" xlink:to="dei_EntityRegistrantName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityRegistrantName_lbl" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="dei_EntityCentralIndexKey" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityCentralIndexKey" xlink:to="dei_EntityCentralIndexKey_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityCentralIndexKey_lbl" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="dei_DocumentType" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentType" xlink:to="dei_DocumentType_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentType_lbl" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="dei_AmendmentFlag" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_AmendmentFlag" xlink:to="dei_AmendmentFlag_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_AmendmentFlag_lbl" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="dei_EntityEmergingGrowthCompany" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityEmergingGrowthCompany" xlink:to="dei_EntityEmergingGrowthCompany_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityEmergingGrowthCompany_lbl" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="dei_DocumentPeriodEndDate" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_DocumentPeriodEndDate" xlink:to="dei_DocumentPeriodEndDate_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_DocumentPeriodEndDate_lbl" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="dei_EntityFileNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityFileNumber" xlink:to="dei_EntityFileNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityFileNumber_lbl" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="dei_EntityIncorporationStateCountryCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityIncorporationStateCountryCode" xlink:to="dei_EntityIncorporationStateCountryCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityIncorporationStateCountryCode_lbl" xml:lang="en-US">Entity Incorporation State Country Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="dei_EntityTaxIdentificationNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityTaxIdentificationNumber" xlink:to="dei_EntityTaxIdentificationNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityTaxIdentificationNumber_lbl" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="dei_EntityAddressAddressLine1" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressAddressLine1" xlink:to="dei_EntityAddressAddressLine1_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressAddressLine1_lbl" xml:lang="en-US">Entity Address Address Line 1</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="dei_EntityAddressCityOrTown" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCityOrTown" xlink:to="dei_EntityAddressCityOrTown_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCityOrTown_lbl" xml:lang="en-US">Entity Address City Or Town</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="dei_EntityAddressStateOrProvince" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressStateOrProvince" xlink:to="dei_EntityAddressStateOrProvince_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressStateOrProvince_lbl" xml:lang="en-US">Entity Address State Or Province</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="dei_EntityAddressPostalZipCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressPostalZipCode" xlink:to="dei_EntityAddressPostalZipCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressPostalZipCode_lbl" xml:lang="en-US">Entity Address Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="dei_CityAreaCode" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_CityAreaCode" xlink:to="dei_CityAreaCode_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_CityAreaCode_lbl" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="dei_LocalPhoneNumber" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_LocalPhoneNumber" xlink:to="dei_LocalPhoneNumber_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_LocalPhoneNumber_lbl" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="dei_Security12bTitle" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_Security12bTitle" xlink:to="dei_Security12bTitle_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_Security12bTitle_lbl" xml:lang="en-US">Security 12b Title</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="dei_TradingSymbol" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_TradingSymbol" xlink:to="dei_TradingSymbol_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_TradingSymbol_lbl" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="dei_SecurityExchangeName" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SecurityExchangeName" xlink:to="dei_SecurityExchangeName_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SecurityExchangeName_lbl" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="dei_EntityAddressCountry" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_EntityAddressCountry" xlink:to="dei_EntityAddressCountry_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_EntityAddressCountry_lbl" xml:lang="en-US">Entity Address Country</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="dei_WrittenCommunications" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_WrittenCommunications" xlink:to="dei_WrittenCommunications_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_WrittenCommunications_lbl" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="dei_SolicitingMaterial" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_SolicitingMaterial" xlink:to="dei_SolicitingMaterial_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_SolicitingMaterial_lbl" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="dei_PreCommencementTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementTenderOffer" xlink:to="dei_PreCommencementTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementTenderOffer_lbl" xml:lang="en-US">Pre Commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="dei_PreCommencementIssuerTenderOffer" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="dei_PreCommencementIssuerTenderOffer" xlink:to="dei_PreCommencementIssuerTenderOffer_lbl" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="dei_PreCommencementIssuerTenderOffer_lbl" xml:lang="en-US">Pre Commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="us-gaap_StatementClassOfStockAxis" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="us-gaap_StatementClassOfStockAxis" xlink:to="us-gaap_StatementClassOfStockAxis_lbl_9bac5f" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="us-gaap_StatementClassOfStockAxis_lbl_9bac5f" xml:lang="en-US">Class of Stock [Axis]</link:label>
    <link:loc xlink:type="locator" xlink:href="lxrp-20240831.xsd#lxrp_CommonStocksMember" xlink:label="lxrp_CommonStocksMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lxrp_CommonStocksMember" xlink:to="lxrp_CommonStocksMember_lbl_5a6ea1" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lxrp_CommonStocksMember_lbl_5a6ea1" xml:lang="en-US">Common Stocks [Member]</link:label>
    <link:loc xlink:type="locator" xlink:href="lxrp-20240831.xsd#lxrp_WarrantsMember" xlink:label="lxrp_WarrantsMember" />
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="lxrp_WarrantsMember" xlink:to="lxrp_WarrantsMember_lbl_e2735e" xlink:type="arc" />
    <link:label xlink:type="resource" xlink:role="http://www.xbrl.org/2003/role/label" xlink:label="lxrp_WarrantsMember_lbl_e2735e" xml:lang="en-US">Warrants [Member]</link:label>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.CAL
<SEQUENCE>5
<FILENAME>lxrp-20240831_cal.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION CALCULATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 08/30/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef  roleURI="http://lxrp.com/role/Cover" xlink:href="lxrp-20240831.xsd#Cover" xlink:type="simple" />
  <link:calculationLink xlink:type="extended" xlink:role="http://lxrp.com/role/Cover" xlink:title="00000001 - Document - Document and Entity Information" />
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>6
<FILENAME>lxrp-20240831_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 08/30/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://lxrp.com/role/Cover" xlink:href="lxrp-20240831.xsd#Cover" xlink:type="simple" />
  <link:presentationLink xlink:type="extended" xlink:role="http://lxrp.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCoverAbstract" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="loc_deiDocumentInformationTable" />
    <link:presentationArc order="500" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiCoverAbstract" xlink:to="loc_deiDocumentInformationTable" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationLineItems" xlink:label="loc_deiDocumentInformationLineItems" />
    <link:presentationArc order="501" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationTable" xlink:to="loc_deiDocumentInformationLineItems" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityRegistrantName" xlink:label="loc_deiEntityRegistrantName" />
    <link:presentationArc order="0" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityRegistrantName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityCentralIndexKey" xlink:label="loc_deiEntityCentralIndexKey" />
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityCentralIndexKey" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentType" xlink:label="loc_deiDocumentType" />
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentType" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_AmendmentFlag" xlink:label="loc_deiAmendmentFlag" />
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiAmendmentFlag" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityEmergingGrowthCompany" xlink:label="loc_deiEntityEmergingGrowthCompany" />
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityEmergingGrowthCompany" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentPeriodEndDate" xlink:label="loc_deiDocumentPeriodEndDate" />
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiDocumentPeriodEndDate" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityFileNumber" xlink:label="loc_deiEntityFileNumber" />
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityFileNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityIncorporationStateCountryCode" xlink:label="loc_deiEntityIncorporationStateCountryCode" />
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityIncorporationStateCountryCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityTaxIdentificationNumber" xlink:label="loc_deiEntityTaxIdentificationNumber" />
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityTaxIdentificationNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressAddressLine1" xlink:label="loc_deiEntityAddressAddressLine1" />
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressAddressLine1" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCityOrTown" xlink:label="loc_deiEntityAddressCityOrTown" />
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCityOrTown" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressStateOrProvince" xlink:label="loc_deiEntityAddressStateOrProvince" />
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressStateOrProvince" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressPostalZipCode" xlink:label="loc_deiEntityAddressPostalZipCode" />
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressPostalZipCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CityAreaCode" xlink:label="loc_deiCityAreaCode" />
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiCityAreaCode" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_LocalPhoneNumber" xlink:label="loc_deiLocalPhoneNumber" />
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiLocalPhoneNumber" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_Security12bTitle" xlink:label="loc_deiSecurity12bTitle" />
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurity12bTitle" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_TradingSymbol" xlink:label="loc_deiTradingSymbol" />
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiTradingSymbol" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SecurityExchangeName" xlink:label="loc_deiSecurityExchangeName" />
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSecurityExchangeName" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_EntityAddressCountry" xlink:label="loc_deiEntityAddressCountry" />
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiEntityAddressCountry" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_WrittenCommunications" xlink:label="loc_deiWrittenCommunications" />
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiWrittenCommunications" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_SolicitingMaterial" xlink:label="loc_deiSolicitingMaterial" />
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiSolicitingMaterial" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementTenderOffer" xlink:label="loc_deiPreCommencementTenderOffer" />
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_PreCommencementIssuerTenderOffer" xlink:label="loc_deiPreCommencementIssuerTenderOffer" />
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_deiPreCommencementIssuerTenderOffer" xlink:type="arc" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis_53cf21" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_deiDocumentInformationLineItems" xlink:to="loc_us-gaapStatementClassOfStockAxis_53cf21" order="50" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_423d5f" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapStatementClassOfStockAxis_53cf21" xlink:to="loc_us-gaapClassOfStockDomain_423d5f" order="51" />
    <link:loc xlink:type="locator" xlink:href="lxrp-20240831.xsd#lxrp_CommonStocksMember" xlink:label="loc_lxrpCommonStocksMember_da0c32" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_423d5f" xlink:to="loc_lxrpCommonStocksMember_da0c32" order="152" />
    <link:loc xlink:type="locator" xlink:href="lxrp-20240831.xsd#lxrp_WarrantsMember" xlink:label="loc_lxrpWarrantsMember_a1130e" />
    <link:presentationArc xlink:type="arc" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_us-gaapClassOfStockDomain_423d5f" xlink:to="loc_lxrpWarrantsMember_a1130e" order="153" />
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.DEF
<SEQUENCE>7
<FILENAME>lxrp-20240831_def.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION DEFINITION LINKBASE
<TEXT>
<XBRL>
<?xml version="1.0" encoding="us-ascii" standalone="yes"?>
<!--XBRL Document Created with XBRLMaster-->
<!--Version: 2.3.08-->
<!--Based on XBRL 2.1-->
<!--Date of creation: 08/30/2024-->
<!--Software architectural design and coding: A'c Dharmapremananda Avt.-->
<!--Copyright (c) 2024 I-NET Business Solutions, Inc. All Rights Reserved.-->
<link:linkbase xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xbrldt="http://xbrl.org/2005/xbrldt" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://lxrp.com/role/Cover" xlink:href="lxrp-20240831.xsd#Cover" xlink:type="simple" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#hypercube-dimension" arcroleURI="http://xbrl.org/int/dim/arcrole/hypercube-dimension" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-domain" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-domain" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#domain-member" arcroleURI="http://xbrl.org/int/dim/arcrole/domain-member" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#all" arcroleURI="http://xbrl.org/int/dim/arcrole/all" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#notAll" arcroleURI="http://xbrl.org/int/dim/arcrole/notAll" />
  <link:arcroleRef xlink:type="simple" xlink:href="http://www.xbrl.org/2005/xbrldt-2005.xsd#dimension-default" arcroleURI="http://xbrl.org/int/dim/arcrole/dimension-default" />
  <link:definitionLink xlink:type="extended" xlink:role="http://lxrp.com/role/Cover" xlink:title="00000001 - Document - Cover Page Information">
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_CoverAbstract" xlink:label="loc_deiCover" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.sec.gov/dei/2024/dei-2024.xsd#dei_DocumentInformationTable" xlink:label="loc_deiDocumentInformationTable" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_StatementClassOfStockAxis" xlink:label="loc_us-gaapStatementClassOfStockAxis" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/hypercube-dimension" xlink:from="loc_deiDocumentInformationTable" xlink:to="loc_us-gaapStatementClassOfStockAxis" order="30" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-domain" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain" order="40" />
    <link:loc xlink:type="locator" xlink:href="https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd#us-gaap_ClassOfStockDomain" xlink:label="loc_us-gaapClassOfStockDomain_10" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/dimension-default" xlink:from="loc_us-gaapStatementClassOfStockAxis" xlink:to="loc_us-gaapClassOfStockDomain_10" order="50" xbrldt:contextElement="segment" />
    <link:loc xlink:type="locator" xlink:href="lxrp-20240831.xsd#lxrp_CommonStocksMember" xlink:label="loc_lxrpCommonStocksMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lxrpCommonStocksMember" order="152" />
    <link:loc xlink:type="locator" xlink:href="lxrp-20240831.xsd#lxrp_WarrantsMember" xlink:label="loc_lxrpWarrantsMember" />
    <link:definitionArc xlink:type="arc" xlink:arcrole="http://xbrl.org/int/dim/arcrole/domain-member" xlink:from="loc_us-gaapClassOfStockDomain" xlink:to="loc_lxrpWarrantsMember" order="153" />
  </link:definitionLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>8
<FILENAME>lxrp_ex991img2.jpg
<TEXT>
begin 644 lxrp_ex991img2.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1"  W &L# 2(  A$! Q$!_\0
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M@/4O$UI::6MN!;J5C=F612-X!P1N!Z5]$Z'H.D:0LMSI,+P1W@5V3S&*]."
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BI13SR!C ZG\ZM6]K%;VZ0V]G$D2#"K&H50/8=J**H5C_V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>9
<FILENAME>lxrp_ex991img3.jpg
<TEXT>
begin 644 lxrp_ex991img3.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  4$! 0$ P4$! 0&!04&" T(" <'
M"! +# D-$Q 4$Q(0$A(4%QT9%!8<%A(2&B,:'!X?(2$A%!DD)R0@)AT@(2#_
MVP!# 04&!@@'" \(" \@%1(5(" @(" @(" @(" @(" @(" @(" @(" @(" @
M(" @(" @(" @(" @(" @(" @(" @("#_P  1" $M G # 2(  A$! Q$!_\0
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MB/\ NU^5N@[4!^7^5NOI[4 1^9/NV^2OK]X__$U!+=FVV&81(KL$4M(0"Q.
MOW>I)P!5K?\ O!\K=#VKB/B<)YO"MJEIN%PFH6]Q& .2T+>>!_Y"JH+FDH]Q
M/0[(W$P<+Y*YQG[Q]<?W:JW6JPV=S#;W'EI-,KO&A<Y94&6/3L"/SJQ%<QW4
M<%U#N:*6,.C =0<$57U&PL+R-9KRS2X>W5C&9$SMR,'\QP:D9#I6OV>N6[7&
MER)<0JVTN"P&>,CE?<5I":<Y_<KP<?>/_P 36)X/:QN?"FF:Q:Z='8'4[2&[
M>&(?*I>-2%]\# _"N@5^6^5NOI0!%YT^[;Y*],_>/_Q-)Y\WF;/)7.,_>/\
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M&WU>2YDDN+JW^T'#B"8@#C:VWY>"W!)]5%=5(_SQ?*WWO3V-.1^#\K=3V]Z
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MG;O]EORIL;_NQ\K?E0 *_P [?*WY4A?]XORMT/:E5_G;Y6_*D+_O%^5NA[4
M,C;_ $9/E;H.U3;O]EORJ&-O]&3Y6Z#M4V[_ &6_*@!L;_NU^5NGI2*_S-\K
M=?3VI8W_ ':_*W3TI%?YF^5NOI[4 "O\S?*W7T]J8C?Z1)\K=?3V%/5_F;Y6
MZ^GM3$;_ $B3Y6Z^GL* 'N_R_=;J.WO3]W^RWY4QW^7[K=1V]Z?N_P!EORH
M:C_NU^5NGI2*_P S_*W7T]J5'_=K\K=/2D5_F?Y6Z^GM0 D;_O)?E;[WI["E
M5_F;Y6Z^GM21O^\E^5OO>GL*57^9OE;KZ>U !O\ WH^5NA[?2C?^]'RMT/;Z
M4;_WH^5NA[?2C?\ O1\K=#V^E "N_ ^5NH[>]-+?Z2ORM]P]O<4YWX'RMU';
MWII;_25^5ON'M[B@!4?]VORMT':@/R_RMU]/:A'_ ':_*W0=J _+_*W7T]J
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MGZT[+?W/UIL;-Y8^3]: !6;>WR>G>D+-YB_+V/>E5FWM\GIWI"S>8OR]CWH
M9&S?94^3L.]39;^Y^M0QLWV5/D[#O4V6_N?K0 R-F\M?D[>M*K-N;Y>_K[4D
M;-Y:_)V]:56;<WR]_7VH %9MS?+W]?:HT9OM$GR=_7V%2*S;F^7OZ^U1HS?:
M)/D[^OL* 'LS;?N]QW]ZKW%W#:JIN9HX5=UC4R2!0S,<*HSW)X [U8=FV_<[
MCO[UPOBC3W\0:W>V:QB5]-TLSVX.#LN)')C8>C#R.#U 8^M5"/-+5V0F5Y/$
M=U?Z1\18)% CTR22VM> /E^RH?Q_>%Z[JRA^RV45JJ?+"BQCGT4"O(=&G.I>
M%]0O%B,9\00Z?>;#P<7-Y*,?7:17LRLVYOE[^OM6M9):+^M@0D;-OE^3^+U]
MA2JS;F^3OZ^U)&S;Y?D_B]?84JLVYOD[^OM6 PW-Y@^3L>_THW-Y@^3L>_TH
MW-Y@^3L>_P!*-S>8/D['O]* !V; ^3N._O2%F^T+\G\![^XISLV!\G<=_>FE
MF^T+\O\  >_N* '(S>6OR=AWI%9LM\G?U]J5&;RU^3L.](K-E_E[^OM0 NYO
M,'R=CWHW-Y@^3L>]&YO,'R=CWHW-Y@^3L>] $;LWGK\G\/K[BO/O#NFWDGQ7
M\1:RH7[+;W%Q:OEOFWR6^GLN!Z8C;]*]!=F\]?D_A]?<5S?A4M_;OC7Y/^8R
MO?\ Z<K6@#SS5I';XK3QF%P%N%(<XVMF?2^!SGC'/U%=OXB;P];ZG:K>:=#/
MJ5V\6T?==H_.CB+[A_=:9>">_P"7*:OI=T?&NIZ^+H?9K6^@M?LI09\QY+"3
M?NZXQ'@CZ8[U4U;6KS4M5^'>J75DSR:GI<5Q/)  ([=FN;&0D@G(4GY1UP2,
M^M(]"I%2Y=-/^ >P6MO'9V\-K;0E(8DVHN[. , #GVJ;<WVD?+_ >_O7.3^,
M]#M]9T?39KC#:Q;M<6DH/R2@/$H [Y/G*>F,9SBNB#9G&!_">_O3.%QDMT2.
MS?+\O\0[U5U*S74M)O-/E!6.ZA>%CZ!E(/\ .K3LWR_)_$.].9FVGY.WK0M[
MDF'X7OI;[PU9R7$>VZC4P7"9^[-&2CC_ +Z4X]L5M*S9;Y>_K7.::W]G^,]3
MT_&V+4(DU"(=MXQ%*/TB/U8UIC5[$:[_ &&;A1J30&Z%O_$8@VW=Z?>XJFKM
MM+S$9GCB21? ^L(JG,]N;<<]Y"$_]FKH>51%5> 0!S7F?B>'6-0^(UM]@2>X
ML8S96E[ C92-6F:<S$=,KY*+GTD->F;GVI\GIWIS5HI7\P16N-1LK=F6XN8H
MB, AW QG('7UP<>N#Z5-!.EQ DT!$D; %65@01[5R7B+0_#PN/MNH::\TFI7
M$%O+ME8!V)*H6 (!"[F'T-=586D6GZ?#9VR,(8E"J"V2!4%.-DGW+",WS?)_
M$>]9?B0M_P (KK7R_P#+A-W_ -AJU$9OF^3^(]ZQ?%4*W7@_7(9E(CDL)U;#
ME3C8W<<C\*!' :#K%C8^*/#,EQ-E9?#EM8C9\V)GD0!3CI[^E>L%F)4[>_K7
MS"-4D%II>HO8SPS10V[R6S,HEB_>(N3@D=BP]1TYKZ+T%I#X:TLO\[&VBRQ.
M23M'-*YT5*7L]?.WX&JS-L;Y.WK0S-Y9^3MZT.S;&^3MZT,S>4?D[>M,YQ0S
M8'R?K4<+-M;Y?XV[^]2!FP/D_6HX6;:WR_QMW]Z 'JS8/R=SWHW-YA^3L.]"
MLV#\G<]Z-S>8?D[#O0 C,V5^3OZ^U*[-L;Y.Q[TC,V4^7OZ^U*[-Y;?)V/>@
M#D-0C\4?VA=K%J-JL4DB-:Q!O+D1-K!E)(8$DX(/'0CUKI; 7$>GPQW9$EPJ
M@2.#PS=R/QKRKQK=V^E?%>VUZZ6Z:/3[&V=T@8D%2]UDE,X8@#([CG'6O6;>
M7S;>.94.UQN&3V/-*YK.FXQC+HR7<WF'Y.P[_6AF;<OR=_7VHW-YA^3L._UH
M9FW+\G?U]J9D#LWEM\G8]ZY[QZS?\*S\5?+C_B4W??\ Z8M70NS>6WR=CWKG
MO'K-_P *S\5?+C_B4W??_IBU #9+S6K8V:Z?IBW-FT9-Q*&!>,B$% J$C=E@
MHZ]^W6MG39+R;2[>:^A\BZ>,-+&!C:W<=3_,_6N"UCX@#0;M+.WL3<00V4MW
M=7)QLC6*(9()(W!7V!L9(W=.*WO"/C33_%"M;PL_VV&,/,/+VI@A2"O)X*LK
M#D\-U- '74444 8EIJEK=B_@CXEM[F2V96(!9PH? ]?E8&J?C-[C_A$+Z&"6
M:WEN?+M5E@DV2(99%CRK#D$;L@U0NO!MCJ'B'4=7U%C=V\RCR;1AM$$P^5IU
M8'<'*I&H(P0%.#\QK, FA%OX=9GD%KX@14\R0NWD[3=)EF))P!CD_P -:I13
M33VU8CJO#^CSZ5I\T=Y=_P!H75Q.\T]PT83S23A<J.!A B_\![=*TY88;NUD
MM[JU2>&0%7CD 96'H0>#5K+?W?UIB,VW[G<]_>LVVW<9S.CS)9^+M>TB1A$]
MQ*E];QLV#(C1JKE?7#H<XZ;AGJ*Q/$$UX?$-QK"S2I:^')H%,*/A)%E7_2&<
M?Q$1NI&>F">]=1XBT:'7-(N;22!#<B-FM9C]Z&7!VNIZJ0<<BN=\+LOBSP3J
M]])\L>O2SJ>?NCRQ 1^!C/Y5M&WQ^B8>1W<C-Y9^7]:?N;^[^M8?AR^FU#PI
MI]U,I,YA5)LGD2+\KC_OH&MO+?W?UK!Z-I] $1FV#Y/UH#-YC?)Z=Z$9M@^3
M]: S>8WR>G>@ 9FWI\OKWJ.9FWQ_)Z]_:I&9MZ?+Z]ZCF9M\?R>O?VH DD9M
MA^3]:=EO[GZTV1FV'Y/UIV6_N?K0 V-FV#Y/UH5FWM\GIWHC9M@^3]:%9M[?
M)Z=Z &.S>?%\OKWI[LVP_)^M,=F\^+Y?7O3W9MA^3]: '9;^Y^M-C9O+'R?K
M3LM_<_6FQLWECY/UH %9M[?)^M(6;S%^7L>]*K-O;Y/UI"S>8OR]CWH 9&S?
M94^3L.]39;^Y^M0QLWV5/D[#O4V6_N?K0 V-F\M?D[>M"LVYOE[^OM1&S>6O
MR=O6A6;<WR]_7VH %9MS?+W]?:HT9OM$GR=_7V%2*S;F^7OZ^U1HS?:)/D[^
MOL* 'N6Q]WN._O6!H?[WQ!XFNL?,;V.WSG^%((SC\W;\ZWG+;?N]QW]ZP/"N
MXPZO<;?]=JER>O\ =?R__9*I?"V(YW6D5?B9X?TU8Q&EY"D@1< ;;9GDZ>Q=
M/SKT%2VY_E[^OM6//HEO=^*-+\0R;A<:?;3V\:<8(F,9)_#RA^9K85FW/\O?
MU]JJ<E)1MT7Z@@C9O,E^3^+U]A3E9MS?+W]?:FQLWF2_)_%Z^PIRLVYOE[^O
MM68Q-S>8/E['O]*-S>8/E['O]*-S>8/E['O]*-S>8/E['O\ 2@!79L#Y.X[^
M],+-]I7Y/X#W]Q3W9L#Y.X[^],+-]I7Y/X#W]Q0 ]&;RU^3L.](K-E_E[^OM
M2HS>6OR=AWI%9LO\O?U]J %W-Y@^3L>]&YO,'R=CWHW-Y@^3L>]9VK:E_9>F
M3Z@\1E6!"Q0. 6]AGOZ>M %UV;[0OR?P^ON*YOPJ6_MWQK\G_,97O_TY6M);
M^+(;WQ3-HL5A<J8(/-^T2*4CDZ'"9'S8[GI]:SOASJO]MP^(M:CMV@34+^&Z
M6-V!*!]/M& /YT 9NMQ7TNF^*%T^%GNEUFT:,+@\A+8]P0!QR2, <]J\Z\->
M?'9>&+69RZP6$"PIO9_+0R:6X4%B3U8]\9)P .*]KT)?-U;Q3"PP'O@I(/3-
MK#7F0\+PR>*1X7B8S6ME:O'NE;:TD4']F$Y*XPQ"=L<GM2/6I3C?EELK._K8
M758;B:W\&/:6@N;J'0EEA4KNVL+BR^;J,  G)R.,\UT?PYU:X-XVER1B59X4
MN!<&0EBRV]JK @COO!SGUXJ'PQ<07NO^&[6VE662V\,SV\P#?ZN3-DVT^^UU
M/XTG@WP_<>$_%<-E<I!%#]BFDC2%B<86U60Y)Z%U8@8&/QH\QQG&5.I3ENG=
M'JKD_+\O\0[T,S;3\O;UJK:WD-]8V]]:MYD,ZI+&_3<K#(//L:ML6VGY>WK3
M/)LT[,YOQ WV/4M"UK:0L%S]EF(/ CG&SGV\P15S[;I)6\9CAO[9CCB;/_+J
M&^RD?[I+/)^(/:NVU&Q@U32;C3KM"T%S$T4BAL$J1@X(Z'W[5EZKH^WP)=Z+
MIMJS>19F*UC+Y)9%_=C)[Y Y-:PDDDOE\B6C%@U2ZL]1UB^MM.>\%W>SH%C4
MER((50 8XY=&7GNWUK?T'5;[5(9VN]+EL6AD"*LH*LXV@[L'IU(_"J>F0WVG
M?#Q5ND,6H?8GN+CY@2D[@R/^3L:M^$[RXO?!.A7=Q(9[F6QMY)G)&6=HE9B?
M<DY_&HD]78:,7Q?JR_\ "0:3H7V=O,,UO>^;N&W N$3;CKGYL_A7;J6VCY>W
MK7B?C;Q&K?$^ :9';WB:;:I'>.;C!AE%S$RQE%5FR<ISC&'R,X(KTV'Q'9C3
MM,N+Q#;B_@\T$L"B?)O()^F>W.*DZ)1?LHRZ7:-]&;YOE_B/>N3\>:E>66@P
MVMG:K/)JMU%II#-C:LV4+CD<KU_"M70/$6G^(K%KS3/,>'</F<;<Y4,/T(K'
M\>%MGAS*X_XGMEW_ -LT'.>9:?X5TMO'%T]U9K<ZAI>E3&*=68'S8O+B5PN<
M' S@'.,GN37IG@O5KBZ\/Q6E[;I#<68$7E1R;B52-?FYP3R<=!S5OPY:36UU
MK#W%J8Y'OYFC9UPS1G;@@_W21^E<YX7A5/'6IQ(IV$W/!8DG,RD\GGO1V/3T
MJ0FGTLT_P.I'BS2)3'&DDA>15(7;RNYVC7<.WSJR_45OEF\H_+_#ZUR.W38_
M'2>'X]%M%2+31?),% =6$FP+TZ=^O6NO8MY1^7MZT'F"AFP/D_6HX6;:WR_Q
MMW]ZD#-@?)^M1PLVUOE_C;O[T /5FP?D[GO1N;S#\G8=Z%9L'Y>Y[T;F\P_)
MV'>@!&9LI\O?U]J5V;RV^3L>](S-E/E[^OM5'6-4MM%T6\U:^67[+9PO-+Y4
M9D<*HR<*H)/'I0!Y?\0"W_"=W)VX_P")3'W_ -F]KN5\3Z7IFBV<UU*P@>Q^
MU),N"K(J@G'O@C [UQ?@[1=(\60>(?%#:A<:DVK7UU;07+3ETAMT:58_*!X&
M!(_Y^@&-#7/'&C:7ILT,6D3W^K0![>WA,*$OM,J[BS$#9FW<GG. .,D4MF=E
M_:4HTXK5/\SMM(US3]<%U+IDWGQVTOV>1@> X ) ]>&'-:C,VY?E[^OM52QQ
M]G298U5I8T=MO<XKG-3M?%#74@M]06WBDN"T*--AF'E$; =I_B^;'MZ9PSD:
ML['7.S>6WR=CWKG/'Q8_#+Q4"G!TF[[_ /3%JVK9;F/38TNOWDZQXD8'AFQR
M?SK&\>EO^%9^*OE_YA-WW_Z8M0(Y#5? ]K>RVLECIMPT*V<D0AM[CRHHLQ)A
M57.%#D*& '(Y[<]!X*\)6OAW3H)HX;BVN)80)+=YMZ0DA<A?3[BC&>  !5N:
MYUVWBA71[%+E#;LS;S@"01+Y8SN'!; /'0DYXK;TN2_ETJVEU.%8+UHP9HT^
MZK=\<G^9H OT444 4\M]FGPH(W/W]ZH2:'IS:W_;KV:G4%38)O,;@ $9V_=S
MAF&<9P2,XJ]EOLT^%&-S]_>K#E]C?*.GK_\ 6IIM; /R_P#='YTQ"^W[HZGO
M[T_+_P!T?G4:%]OW1U/?W^E(!07\QOE'0=ZI16L%A8_9[*VB@A4LPCC^506)
M8G '<DG\:N@OYC?*.@[TRX+^2?E'0]__ *U._0#E[=K[0?$C6)MXY-,UB[DD
M@D$Q#V\IB,CH5*X*LR.P(/5SQ76_/_='YUSGBOS(X]&O% 'V?5+<DYZ!R8C_
M .C*EU77)K"_MM/LM+EU*]FC>9HH943RXU(&XER!RS  =3SZ&J:O9AL;B%M@
M^4=^]*"_F-\H[=ZP](U:ZU":YL+[36T_4+4(\D7G"1&1]VUE<#D':PY ((/L
M3N OYC?*.W>H=T]0&Y;>GRCOWK)U#6[*QUS2=(N&*W>IF9;91R&,:;VR>W%:
MS%MZY4=_XJ\T\0:A;ZMKMEX@TN7[?:Z)!%=))9YFW"2X\N4*%!+'RXI!@<UI
M"'-+7;]>@FSTR0OL/RC\Z?E_[H_.LO2M6CUK2$OK>"6%79T,5P-DD;*Q5E8<
MX((-:GS_ -T?G6;33LQC8R^P?*/SH!?>WRCMWI(R^P?*/S_^M2@OO;Y1V[T
M,<OY\7RCOWISEMA^4=N]-<OY\7RCOWI6+[3\H[=__K4 29?^Z/SIL9?RQ\H_
M.G9?^Z/SID9?8/E'Y_\ UJ !2V]_E';O02_F+\HZ'O0I;>_RCMWH)?S%^4=#
MWH 9&7^RI\HZ#O4V7_NC\ZAC+_94^4=!WJ;+_P!T?G0 V,OY:_*.GK0I?<WR
MCKZ^U-CW^6ORCIZ__6I5W[F^4=?7V^E "J7W-\HZ^OM4:%_M$GRCKZ^PIZ[]
MS?*.OK[?2F(7^T2?*.OK["@![%]OW1U'?WKG_!K-)X7CGX)FN;F;.>NZXD;^
MM87A[Q!=MJ6NWVIW;2:?=1G4K%6X$-O&QB8+[$1I)]9:Z+PC;S6G@S1X98]L
M@M8RX)Y#$9(_,UHURQ:?=!N;B%_+7Y1T]:12^Y_E'7U]J$+^6ORCIZ__ %J1
M2^Y_E'7U]OI68!&7\R7Y1][U]A3E+[F^4=?7VID9?S)?E'WO7V'M3EW[F^4=
M?7V^E !E_,'RCH>_THR_F#Y1T/?Z4GS^8/E'0]_I[4?/Y@^4=#W^GM0 YR^!
M\HZCO[TTE_M"_*/N'O[BE8O@?*.H[^_TI"7^TK\H^X>_N* '(7\M?E'0=Z12
MV7^4=?7VI4+^6ORCH.]-4OE_E'7U]OI0 [+^8/E'0]Z1MS. T:D8[FC+[Q\H
MZ'O_ /6HR^\?*.A[_P#UJ .3T:\OKS7O%D-U<+);V5XMK:Q; /)3[-#(WS8R
MV6E/7I@ 5F_"72+/3/AGI5Y9V<UJ^JVT%]<13,"?--O%&6&,X#",-U[]N@SK
M[6)]!7QKJ4<L<"CQ%912R2<JL3Q622?^.,W/:MKPO:W&H?!;PW;V=P())='M
M-DP9AM_<K\PQS[T :^B6\\6JZ_+)"56>^62,EOOK]GA7(]LJP_ UQ.G3-)\<
MM5L]J[TL;QUP6R0PL!SQCJO8D^N.,]?I^CZU;^(7U*YU<3VKIM6SPVU#\N&4
MDG!.#D=/3'-<E.VJ:;\4;^ZM;%I;AK2]EMXV5B)A_P 2]>,=L@C/;!]*1TPG
M[LGY+\&9?PJ\,ZS9^*-2UC4M2\Z6T5]/EMS\@C8V]BZX09 8*FUSGYB 0!5W
MXI7%_#K6B+9-=Q&9XX9&M&*R;3>6W&_(" XVDG(.['?-==I=_JG_  DMQ:KH
M/V:QE8R/=E=AE?:HRP]>,9[@#' K6N-*AN=72^8D3);R6ZX;Y0KLI)QCKE!^
MM%M IU%[3GEU.9^&MU>7/AETNL9A:"-(PY98U^S0G:N0..2?J37=MNP?E[>M
M>3Z1YW@OQDFCS),]G+\D;),',F_[-$LKH3\HWAE[]3@ "O6/G*]!^?\ ]:FM
MB\7%*?-'9ZH<I?8/E'3UI%+_ #?*.OK4,EW#;*OVB:&'C_EI(%_G55=:TK<R
M_P!I6>=W_/=?3-!QB:TS?V'J7RC_ (])>_\ LFO"X_M^C_!_3I- W+)!JEA)
MY/F,S3 V\)*ARP(.3D9)'&.!T]@\1:_H]EH-VMQJ5L#<1-;Q*LF]I)&4[5 &
M22:\=T5]8UE-%\(V5O;VT,Z6^H>=<2KYA,26JL43/S!4;<1QG(]Z1O#X)?(V
M_AUH^L76@ZAXJUU0E]);31,-A(N-\-NZSACUSL]^2>>*] TYDM_A]9ZE]GB>
MXL]+66,N.05B#8]AD"F1^%ET_P $)I-U<3ZE)::>+4.TC*&VP[.$7 &<>YYZ
MUYXOB33]$^&=W-?-/:SQ@6$=O;R"5XU,4<6&3.& D;:>X) ZBGU+4'*BY=FC
MUKPS,+KPQIVI_98;>6^MHKF58AM7<Z!C^IKSSQI]NF^,GABTM=.N+H.D,LCP
MJ66W6.Y#%G]!COTSQW%=!\+?$7]N^ -.5M/FL)[&"*UDM[CB0;8DP^.P8'(S
MVJGI/B"VUCXW7\%O;S(^FZ;)9RF3&UG$Z'Y2">Q'7'4>M!S23B[,]#RWVD_*
M/N#O[UYCH5\;'XBZE)J#00VTD\EO;L&;<\CRK\K#& 21QCKWQ7IV6^TGY1]P
M=_>O'_B7X3CDU33=2BAN(8UNU=9[2X=)(YF9F=P1T^51ST&2.])G9AIQ7-"7
MVE8[&1POQDW-M&[0=HRV,G[1TKLF+>6?E'3UKP?2M/6XOX?&6O7DFI:O9:K]
MAAG;*K;VJIYFQ4!()Y;YCECD\]J]P@N%NK*&YAY2:,2(3P2",CM085*3@E+O
M?\"T"^!\H_.HX2^UOE'WV[^]2@O@?*/SJ*$MM;Y1]]N_O3,1R[^?E'4]ZI7&
MI6MK<"&YE5)&C:0+R257EB,#G%9]WXHTO3Y98+IGCECF$)3:<LS LN/4$ \U
M5UIM'OM)FU>X3[0+>TDE6,3M&VW;N(P""I( YZB@$FVDC;L]2L]3B$VGW,5S
M$K[2\;9&<>M<E\3]:FTGP-=P1Z;/?/JJ2Z>J0L-R;[>5M^#UQLY'7'3)X/2:
M+9V5KIT3Z?;BWCN,3,FXG!9<UYQ<^,5\1^)M/TF2$)<Z1XH\EB@(5D"W"IR>
MK84$]N105RR=]-CL/!VEW.DZ !<NDC7=W+>+M)^59,L <CJ >:\OAT72V\4>
M,=0FTF!KJTTVYDM;E_WDJGS[M2RD\J<%EZ\BO=YCAHV;:HW=2V.QKA&L%A\/
MZ_9-;K_:5Z;L1.L+.6CD9VC!8*>/GSC/&3[T&]&22LWV-BU\3:9;WL>DS2)'
MY6GP77VAG41,K>8  ?7$3GTQ5;QF3)>^#S'@YUI2I!QG-K<=^WUKR%=-?7/%
M-]I_AVZ674=)LW@%I)<D(D;37B;65N3@,JKUV[^F#5'Q7XN\13WTELIN(=3T
MV,J[695XM/D2/4 KX=ER2@!# ?P'NH!$S:OAHQ@ZD97LVFNOD['K^CMJVJ30
MM#KGF"PD:VNHBS!I6BD>.1L'J"RE0>^,]1BMOQ[N_P"%:>*OE'_()N^__3%J
M\G\#S:EI/B"U\RZ1[_5=6D@U"522MR/-OR2JM]S)C0G:!R#ZUZ+\15U2\T6Q
M\-Z;<P6?_"0W3:7/<2PF8QPO;S,Y5=R_-A, DX&>AH.2I#D:7DG]YJQR:TDM
MI_9L$,MN83YPD; W^4NSGJ.<9P#QGO@5JZ.VJ-I%N=:2%+_;^^$)RF<GI^&*
MY[4-<_LC4ULHK^PCCCA<S1S3QK)D1J(R S+U./;&<D<5JZ%K%OJFGPI_:5E=
M:@D2M<1VTR/L;OD*Q[^^*#,W:*** *7S?9I\*,;G[^]6'+^6WRCIZ_\ UJK_
M #?9I\*,;G[^]69"_EM\HZ>M #LO_='YU&A?;]T=3W]_I4F7_NC\Z8A?;]T=
M3W]Z  %_,;Y1T'>F7!?R3\HZ'O3P7\QOE'0=Z9<%_)/RCH>] &)XML=4U#PE
M>V^CQPMJ2A)K43-A#*CJZ;CCIE1FGZ%X?M=$A>2,R3WDZJ+FZFF=WF89.?F)
MVC+,=HP!D\5N2%_+/RC\Z=E_[H_.GS/EY>@K',G=;_$*WDX"WNG21XSU:*52
M/TE;\JB\3>++?0TD@MH5U/5502+813 2; "S.W!VJ%5CD]2 !R11XLN(]+CT
MSQ'</'#!IMT#<2LV%2"0&-R?8%D8_P"[4_A>WF;3[G5+R I<ZM,UVZ2?>2,@
M+$A&.HC5,CUS6EHV4I*Z#R*5W--XNOY-)M)/+T2'9]MF5R&N]R!Q F.BE60N
MW7#;1U)&Q::'INE:A=WFGV4=O-?LK7!1B Y1-JG'08'IBF>'M MO#.CQZ58M
M)-$CNWF3OEV+$GDX[#"CV K5E+[X_E'?O[5+>MHO3\P.4:W\1Z5J.JVNCZ3#
M/;WUQ]HANIK@+%;ED42!T'SGYE+ +UW8RO6KWAS4+Z:.[TS5;B.XU73IC%,R
M@1^:APT<@09V@JP_$,.U="Y;8?E'YUS'B6*.SO=+\1+#&)[.ZCAFEZ,8)3Y;
M*3C[H9U?'^SFA/FT:'L=/&7V#Y1^?_UJ4%][?*.W>A-X0?*/SH!?>WRCMWJ
M&.7\^+Y1W[TK%]I^4=N__P!:D<OY\7RCOWITA;8?E';O0 _+_P!T?G3(R^P?
M*/S_ /K4_+_W1^=-C+^6/E'YT (I;>_RCMWH)?S%^4=#WH4MO?Y1V[T$OYB_
M*.A[T ,C+_94^4=!WJ;+_P!T?G4,9?[*GRCH.]39?^Z/SH CCW^6ORCIZ_\
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MT?G3(RVW[HZGO[T  +^8WRCH.],N"_DGY1T/>G@OYC?*.@[TRX+^2?E'0]Z
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MS!\HZ'O]* %<O@?*.H[^]-)?[2ORC[A[^XISE\#Y1U'?WIA+_:5^4?</?W%
M&3JD.K2R6C:=((U4/YO[S;G*$+QM.><'MC'?I7GWB34-5T_P[:Z9>3C5M1N[
MNQNK,K/^ZF6*\M%8E]OR[FD7L1U(]*]85F\K[H^[ZU\^Z';W'BR+P#I]E>+:
MKI&GQN?+<%+A8FTR=T?Y3CJ1@8.0,GJ*"X1<M5T/9= U@W?AK1[S49X4NKNU
MCE8%@NYB@9L#\ZQO'EQ::GX16&WNHYE;4M.1VMYOF0->0]&7E3@Y!'/<5@>&
M->TW4='T73;IY[75+.U)L[1)D#WGEV\+.1GY=P$XP-V1G/'.':M!&?ACH6J>
M&;=(HM0U#2+M8K[.YD>Y@*JS+G:0-O.& P0!SF@JK!QFXM6(/AM9VMO:>$+R
MS2=3J.AF>47&5.]8K*'@$ @;8E/OG/>O7#NY^4?G7*S6=O:_$'2!;6L4*IIE
MQ"HC7:%19(-J@ 8 &3@5U9+8/RC\Z0Y[1]!%W;%^4=/6J5W?16:%IE+EFVI&
MG+R-V51W/\NIP!FLR'6Y/,O8Y+<-+%-Y%O%&V7F..G/TR3T Y/ JW9V,_P!J
M:^OG2:\/RC:3LA']U,C\SU/MTI[F;BXNS$M[6ZN+M;W4XUWKS#;ALI![]/F?
MW[#@=3G3RWVH?*/N'O[T_+^9]T=/6F9;[4/E'W#W]Z"1DZM)"T;# ?Y20W(S
MQZ5X_%I=YX%\9V5K9W4;VTNV.%9=I)B:2WB= JJN&& V[YNW'4GV-BQ"\#[P
M[US'B^"%H-.N)((S.FH6J+(5!909TR <9 .!^5#1V8:LX7@]4]T12[O^%PZ:
M=HS_ &#<]_\ IX@KKD+?-\HZ^M>7:IXOTNU^,>G6]O<+<W4=I)ILT*[LPR//
M:GYN#@;7!!. W0'->GH_!/RC.3]Z@Y7"2L^C.4\>;OL>AY4?\AS3^_\ TW%=
M8"_E1_*.W>O&XWUGQA\9[JQOKN\MM+T"9YHA"H$-TT;VTD<;[D(RI8G<IW?,
M1P!S[("_E1_*.W>@D>Q?8?E'3UH4OM'RCIZT,7V'Y1T]:%+[1\HZ>M '%^(?
M$&APR-#JHD/V"[C=1"0Y,H4R+PIR.!T(ZLOJ*ZBQNEO;2&\A4&.6,.IW=0>?
M2I%@CWNQMXBQ;DX&3^E2*I0[4C55 Z X'\J!WNK!EOM1^4?<'?WI[%\K\HZ^
MM,RWVH_*/N#O[T]B^5^4=?6@1AZMINHWUY%-:W20(D,B,&9\DL, _*0..??.
M"",<X>I>%;A_"%WI]ZTNMR1L]Q;+))B1F /EJS$@-@GJ2.U=PS-L/RCIZU%,
MS+;2,%&0A/'/;THW+A.4)*4=T?->O6_B;4KN/P=;RK;!;G=%J =3(UR_F0MA
M -H&-R'=P,A@">G8:_X5\5LMEH^A7,^G07UJMGJ-Q#")C'YF\2;'/"!2!DX)
MP>"#S776VH:TNJ6DT/AA$-Q&GVFY\@QM&6=BX.?0;3CGDMD]">WBW;6^4?>;
MO[TK&\L1*4G.VYX[H6CZBWB6#0&T>[T_2M NSJD5ZL92">4%D,0RP!!5BPX.
MT@DXR*ZR'6?#@\76^I0^=_:5_:16RP+@*L;/(ZLW;)8-SDYRN,[AGMMI>-D>
M-2IR"">"/RJM'IEC&5$>GVJ; -NU -OTXXH6AC.HY2<GU.8/@2U;6+/4O[1N
M08+YKPQIMV2$F1E4Y!( ,K<@@GBNS<ML;Y1T/>FL7RORCKZ^WTIS%O+;Y1T/
M>F3*<I.\G=B2%]T7RC[WK[&G(7P?E'4]_>FR%]T7RC[WK[&G(7P?E'4]_>@D
M3+>8?E'0=_K0Q?<ORCKZ^QHR_F'Y1T'?ZT,7W+\HZ^OL: ([B/S[:6&2,,CJ
M589Z@BLR+PYHL,T4T.FPI+$%".&.5"C"\^P/%;#E_+;Y1T/>G9?^Z/SH YZ^
MDUY;IUTJ&-U\N8DRX*^;L'E@_,#UZXXQGU&-/2SJ1TNV.K+&+WRQYPCX7=WQ
MR<?3)^IJA<-K2ZGLTZ&-[?;(9"Y 7S-J[ 3G<.>I /&>^*O:.=4.D6YUI85O
M]O[X0G*9R>GX8H N22)%&TDC!$0%F9C@ #N:I?VQI.Y5_M.URZ"1<S+\RG)!
M'/(X/Y5<FC6:)HGSM=2IVD@X/N.E<]<>"/#%Y:K;7FF_:85145'D<@!1@'KU
MQW[T ;"/YEE))&R/&^YE8'(8'D$5;?S/+;A>E4H85M].:W@14AB!C1>?E4<
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M[4SDG+GDY=Q[>9L/"]*%\S:/N]*5O,V'[O2D7S-H^[TH($3?\W3[QI?WF_\
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M6TI^:%I)F?:<=< @?A6B=E=/781%X4MTTEM4\,VX5+739@;5>?D@D7>J_P#
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M>U*_F;&Y'0]J $D\S=%]W[W]#2IYF#TZG^=))YFZ+E?O>GL:5?,P>5ZGM[T
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MZT-YFY>5Z^GM547UNVJ/IZSJ;A(Q(R;3PN>N>E9NN75Y;W^C1V]QY:S7020
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M/!H5M-;6\\TRRS-,3*P)!...GM572O"UGH^KRZC%<2RW-Q&T;LRJH(WENB@
M<GMCN3DG-,3L._X2"%IF"V%^QB&646IR,\\\\?CBK+:U!LR;6^[?\N3_ .%<
MEJ7PKT'6K[4+RXU'5(O[2,GGQPSA58,K*P/R_-]_(W9VX &!Q76ZQHD.L>'_
M .RI[J>"-]@\R JKC!'3((_2@-#,UR^>_P!-DM+>RO#)(5.3;,H&"#SFF?\
M"0:I&+5+?0+QHE7$HDBPQXP-I!(_.NCO;&&^TN>RFW>5-&8VVG!P1CK5+1-#
MMM!L7L[6::2.29YB97W'+=>?P_/)I6'*=XJ*1R5O)J#>*'UBXTNZBC+!BBQ%
MR/EQ[51U'3YDUO6KZWAN)X]8:$E9K9HQ;"-0-JY^]N8;C^%=AI?AVWT>_:[C
MNI9I6C9#N5%!R^XG"J/7 ].?4U%XS\$Z7XXL+33]5N+NW2TN!=1O:2"-PX5E
MZD'LQJHR<;VZB<KQ2ML<WJ$OB*^BL9O[-N;2>V4H'BC8=2/7IQ[U<@O/$/\
M9<MI,E\TY9?*D6$[ASEMS?E3++X8:7;_ &K=KNN70G2.,I<WGF(A20MN52,
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=7;W-KI-M:W=VUW<11A'F;JY'<^OU[UH451!__]D!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>11
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.24.2.u1</span><table class="report" border="0" cellspacing="2" id="idm139979644123392">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover<br></strong></div></th>
<th class="th"><div>Aug. 31, 2024</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">LEXARIA BIOSCIENCE CORP.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0001348362<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Aug. 31,  2024<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">000-52138<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation State Country Code</a></td>
<td class="text">NV<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">20-2000871<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address Address Line 1</a></td>
<td class="text">100 &#8211; 740 McCurdy Road<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address City Or Town</a></td>
<td class="text">Kelowna<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address State Or Province</a></td>
<td class="text">BC<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address Postal Zip Code</a></td>
<td class="text">V1X 2P7<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">250<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">765-6424<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCountry', window );">Entity Address Country</a></td>
<td class="text">CA<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre Commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre Commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lxrp_CommonStocksMember', window );">Common Stocks [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Common Stock, par value $0.001 per share<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LEXX<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
<tr class="rh">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_us-gaap_StatementClassOfStockAxis=lxrp_WarrantsMember', window );">Warrants [Member]</a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentInformationLineItems', window );"><strong>Document Information Line Items</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Security 12b Title</a></td>
<td class="text">Warrants to Purchase Common Stock<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">LEXXW<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NASDAQ<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentInformationLineItems">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentInformationLineItems</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCountry">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>ISO 3166-1 alpha-2 country code.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCountry</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:countryCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14a<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lxrp_CommonStocksMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lxrp_CommonStocksMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_us-gaap_StatementClassOfStockAxis=lxrp_WarrantsMember">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Details</a><div><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">us-gaap_StatementClassOfStockAxis=lxrp_WarrantsMember</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td></td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td></td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>12
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M" !H4259JQZ4(-P$  "5%0  &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;*V8:W/B-A2&_XK&V]E/F]@2UV2!&>*0ELF-AC3)M-,/PA:@B6VYDAR2?U_)
M!IMNS3&3V2_X>EX>2SKOD338"/FJUHQI]!Y'B1HZ:ZW3<]=5P9K%5)V*E"7F
MR5+(F&IS*5>N2B6C81X41R[QO*X;4YXXHT%^;R9' Y'IB"=L)I'*XIC*CPL6
MB<W0P<[NQ@-?K;6]X8X&*5VQ.=-_I#-IKMQ2)>0Q2Q07"9)L.73&^/RB16Q
M_L839QNU=X[LIRR$>+47TW#H>):(12S05H*:PQOS6119)</QSU;4*?_3!NZ?
M[]2O\H\W'[.@BODB>N:A7@^=OH-"MJ19I!_$YC>V_:".U0M$I/)?M"G>;7L.
M"C*E1;P--@0Q3XHC?=\VQ'X /A! M@%Y0[C%'^64EU33T4"*#9+V;:-F3_)/
MS:,-'$]LK\RU-$^YB=,C7[PQ.7"UD;(WW& ;=E&$D0-AXVQUBEKX&R(>:?\W
MW#4$)08I,4BNUSJ@=RF"S/2U1M.D&&FVQV[,2VBJ6:SJ  O!=KV@'<SG*J4!
M&SIFM"HFWY@S^OH%=[WO &ZKQ&U!ZJ-)HKG^0 ]LQ966U'#?T9C54<(Z-Y.7
M\<-TC"ZF]W-_.KGS)\B_?YB= HCM$K%]#*)O&E72R+1KR-[1-?NH@X25/,_#
MK7:_U24 5J?$ZH!B94<_?J2U#0:']T^N 8AN"=$%5<:&(,PIKB*ZJJ. XY<T
M4@S@Z)4<O6/Z:!(SN>+)"OUJXO4:^2).:5+;4[!>$U>_Y.H?UTDS)KD(T20)
MD7&7VOZ"E4J?:#**LQ+M[)@FN^(10W=9O*@W+UC##.B3#L&M/L"#O<I O6.(
MIDD@9"ID85US;9K+=&1FLL\DH0AKVZY!^>X) MQS>'P,X"-]1]/0]"I?\J"@
M/-R #9+$.S%EW^OW,$18F3\&S7I'. Y#8]6J/.;^CVOQ8#WL>>CKES[!^#OJ
MM3UT&_B9#(U?"QI"P)7]XZ/\?P?JVXM[B1[%)JG%A=6N[=PHH1!9Y?KX*-O?
MD17CT*#-I'CC25 _#&')"Q\BJXP?P];] ]E,*&WJTI\\/9P>L. 3?D%DUH/@
MJH* 84?/>W!LIK6'86 !TO$@D*HB8-C";T1@6F6V%@GD;PTBO6[GI-L&_197
MM0##%O[C6"\\K98*%O+'$$]5 ##LWL^2:\T26R7C+-E:6>T,L4&HJ5J2J@00
MV*CG(N(!U[:$WYI\DYQ&M3-66*61IW)\ MOS3+*\>9A)^&*R9>8[3*+[Y;)^
M/#7H-9+M3?-A9_X?V52IS) U L*RC8"5LQ/8BRU<7K]%\*K07[?,IN#?M4B@
MT"<7(*0R>M+^Z2LFT.<_2UP5  +[]9P%F;16@LD"/7(=U?IL@\A^_WQ#*97H
MC4890[]XIV:9@E(SB-2:2G P5%6!P*;^*&EHDWK^$2]$?4K# F9]]P*15&6!
MP(Y>MMWD/5C39,4.+C@;A.[&\\OQ[Q!351@([.?/5-JE;T.6@!J?'7-5L2!G
M/SU+P*KQV8V%JI:T&FK)45G2(%)VC19HEDDS9%3AN[O4@5"K,M."RT)S>C0(
MV/1XAE"JNM*""\#Q^=$@=#@_W+U--KMA>4OMHEVAB"V-DG?:,\8EBSW XD*+
M--]W6PBM19R?KADU9<Z^8)XOA="["[N55^[$COX%4$L#!!0    ( &A1)5F?
MH!OPL0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_8&YB:N*1
M&+9 8;"-0O-A7Y58=@1Z\62Y<_KKI[-L)VEU9=V'L<VAR=T]NKM'=R>9KEMW
MDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;<%(R6=[<
M9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQMV)8RY20
MIV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!IK5>%E#/!
M)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;.<V"3J9B
M+7D%=*RHC_#K3), Z)Q17B@%JXUF X?)8Q1\V .7\@%:^*VZBMU7)/3B4PEM
M(+#52?2$1C&$"0K$OXP68E^$O?VML*01C\9][/QN]*!_[XSC]Y97HA_TOIKS
M8]$7>'36-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B<&GY85FS
MX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;"5R$&_H5
M[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R%UZ*3N7S
MJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,31S"?@,41
MP+ \& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?^$[S/$VS
M#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WBDXCM%*\U
M(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7XC&894IT,
M/O'^8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]74_P$4$L#
M!!0    ( &A1)5F7BKL<P    !,"   +    7W)E;',O+G)E;'.=DKENPS ,
M0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<'FE [3BD
MMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X99K>]9!:G
M<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.56QIXT^7^
M=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,<6*T_C6"
MR0_L?@!02P,$%     @ :%$E6:K$(A8S 0  (@(   \   !X;"]W;W)K8F]O
M:RYX;6R-4=%NPC ,_)4J'[ 6M"$-45Y VY"F#8V)]]"ZU"*)*\>%C:^?VZH:
MTE[VE-S9NMQ=%A?BTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z*0CZFL6&P
M9:P!Q+MTFF6SU%L,9KD8M;:<W@(2* 0I*-D1>X1+_)UW,#ECQ ,ZE._<]'<'
M)O$8T.,5RMQD)HDU75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\M(?8,V(/'U:-
MY&:6J6"%'*7?Z/6M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO8O0]C.=0XIS_
M4R-5%1:PIJ+U$&3HD<%U!D.LL8DF"=9#;E9T!N[RZ .;<L@F:NJF*9ZC#GA3
M#O9&3R54&*!\4YFHO/93;#GICEYG>O\P>=0>6N=6RKV'5[+E&''\GN4/4$L#
M!!0    ( &A1)5DD'INBK0   /@!   :    >&PO7W)E;',O=V]R:V)O;VLN
M>&UL+G)E;'.UD3T.@S ,A:\2Y0 U4*E#!4Q=6"LN$ 7S(Q(2Q:X*MR^% 9 Z
M=&&RGBU_[\E.GV@4=VZ@MO,D1FL&RF3+[.\ I%NTBB[.XS!/:A>LXEF&!KS2
MO6H0DBBZ0=@S9)[NF:*<//Y#='7=:7PX_;(X\ \PO%WHJ45D*4H5&N1,PFBV
M-L%2XLM,EJ*H,AF**I9P6B#BR2!M:59]L$].M.=Y%S?W1:[-XPFNWPQP>'3^
M 5!+ P04    " !H425999!YDAD!  #/ P  $P   %M#;VYT96YT7U1Y<&5S
M72YX;6RMDTU.PS 0A:\295LE+BQ8H*8;8 M=< %C3QJK_I-G6M+;,T[:2J 2
M%85-K'C>O,^>EZS>CQ&PZ)WUV)0=47P4 E4'3F(=(GBNM"$Y2?R:MB)*M9-;
M$/?+Y8-0P1-XJBA[E.O5,[1R;ZEXZ7D;3?!-F<!B63R-PLQJ2AFC-4H2U\7!
MZQ^4ZD2HN7/08&<B+EA0BJN$7/D=<.I[.T!*1D.QD8E>I6.5Z*U .EK >MKB
MRAE#VQH%.JB]XY8:8P*IL0,@9^O1=#%-)IXPC,^[V?S!9@K(RDT*$3FQ!'_'
MG2/)W55D(TADIJ]X(;+U[/M!3EN#OI'-X_T,:3?D@6)8YL_X>\87_QO.\1'"
M[K\_L;S63AI_YHOA/UY_ 5!+ 0(4 Q0    ( &A1)5D'04UB@0   +$    0
M              "  0    !D;V-0<F]P<R]A<' N>&UL4$L! A0#%     @
M:%$E6<.USI+O    *P(  !$              ( !KP   &1O8U!R;W!S+V-O
M<F4N>&UL4$L! A0#%     @ :%$E69E<G",0!@  G"<  !,
M ( !S0$  'AL+W1H96UE+W1H96UE,2YX;6Q02P$"% ,4    " !H4259JQZ4
M(-P$  "5%0  &               @($."   >&PO=V]R:W-H965T<R]S:&5E
M=#$N>&UL4$L! A0#%     @ :%$E69^@&_"Q @  X@P   T
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;72YX;6Q02P4&      D "0 ^ @  =!0

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.24.2.u1</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>3</ContextCount>
  <ElementCount>23</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>2</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>3</UnitCount>
  <MyReports>
    <Report instance="lxrp_8k.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>000001 - Document - Cover</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://lxrp.com/role/Cover</Role>
      <ShortName>Cover</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File>lxrp-20240831.xsd</File>
    <File>lxrp-20240831_cal.xml</File>
    <File>lxrp-20240831_def.xml</File>
    <File>lxrp-20240831_lab.xml</File>
    <File>lxrp-20240831_pre.xml</File>
    <File doctype="8-K" isOnlyDei="true" isUsgaap="true" original="lxrp_8k.htm">lxrp_8k.htm</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="26">http://xbrl.sec.gov/dei/2024</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>true</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>18
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "lxrp_8k.htm": {
   "nsprefix": "lxrp",
   "nsuri": "http://lxrp.com/20240831",
   "dts": {
    "schema": {
     "local": [
      "lxrp-20240831.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/2006/ref-2006-02-27.xsd",
      "http://www.xbrl.org/dtr/type/nonNumeric-2009-12-16.xsd",
      "http://www.xbrl.org/dtr/type/numeric-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/arcrole/factExplanatory-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/2020/extensible-enumerations-2.0.xsd",
      "https://www.xbrl.org/dtr/type/2020-01-21/types.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-roles-2024.xsd",
      "https://xbrl.fasb.org/srt/2024/elts/srt-types-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-gaap-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-roles-2024.xsd",
      "https://xbrl.fasb.org/us-gaap/2024/elts/us-types-2024.xsd",
      "https://xbrl.sec.gov/country/2024/country-2024.xsd",
      "https://xbrl.sec.gov/currency/2024/currency-2024.xsd",
      "https://xbrl.sec.gov/dei/2024/dei-2024.xsd",
      "https://xbrl.sec.gov/exch/2024/exch-2024.xsd",
      "https://xbrl.sec.gov/naics/2024/naics-2024.xsd",
      "https://xbrl.sec.gov/sic/2024/sic-2024.xsd",
      "https://xbrl.sec.gov/stpr/2024/stpr-2024.xsd"
     ]
    },
    "calculationLink": {
     "local": [
      "lxrp-20240831_cal.xml"
     ]
    },
    "definitionLink": {
     "local": [
      "lxrp-20240831_def.xml"
     ]
    },
    "labelLink": {
     "local": [
      "lxrp-20240831_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "lxrp-20240831_pre.xml"
     ]
    },
    "inline": {
     "local": [
      "lxrp_8k.htm"
     ]
    }
   },
   "keyStandard": 23,
   "keyCustom": 0,
   "axisStandard": 1,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 2,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2024": 2
   },
   "contextCount": 3,
   "entityCount": 1,
   "segmentCount": 2,
   "elementCount": 30,
   "unitCount": 3,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2024": 26
   },
   "report": {
    "R1": {
     "role": "http://lxrp.com/role/Cover",
     "longName": "000001 - Document - Cover",
     "shortName": "Cover",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "From2024-08-31to2024-08-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lxrp_8k.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "From2024-08-31to2024-08-31",
      "name": "dei:EntityRegistrantName",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "strong",
       "p",
       "td",
       "tr",
       "tbody",
       "table",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "lxrp_8k.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CityAreaCode",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "us-gaap_ClassOfStockDomain": {
     "xbrltype": "domainItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "ClassOfStockDomain",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "auth_ref": []
    },
    "lxrp_CommonStocksMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://lxrp.com/20240831",
     "localname": "CommonStocksMember",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Common Stocks [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationLineItems": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationLineItems",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentInformationTable": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentInformationTable",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "documentation": "Container to support the formal attachment of each official or unofficial, public or private document as part of a submission package."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period. The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "DocumentType",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Address Line 1",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address City Or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCountry": {
     "xbrltype": "countryCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressCountry",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Country",
        "documentation": "ISO 3166-1 alpha-2 country code."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Address State Or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Incorporation State Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Pre Commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "Security12bTitle",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security 12b Title",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "us-gaap_StatementClassOfStockAxis": {
     "xbrltype": "stringItemType",
     "nsuri": "http://fasb.org/us-gaap/2024",
     "localname": "StatementClassOfStockAxis",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Class of Stock [Axis]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "TradingSymbol",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "lxrp_WarrantsMember": {
     "xbrltype": "domainItemType",
     "nsuri": "http://lxrp.com/20240831",
     "localname": "WarrantsMember",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Warrants [Member]"
       }
      }
     },
     "auth_ref": []
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2024",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://lxrp.com/role/Cover"
     ],
     "lang": {
      "en-us": {
       "role": {
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14a",
   "Subsection": "12"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>19
<FILENAME>0001640334-24-001396-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001640334-24-001396-xbrl.zip
M4$L#!!0    ( &A1)5GPH6&Q\@0  !48   1    ;'AR<"TR,#(T,#@S,2YX
M<V3-6-MNXS80?2_0?V#UTA:H+#ON!HEA9Y'+;A$@28$D;?.VH"G:)E8B59*R
MG;_OD!)ER9:\DA(4ZR?1<\Y<.*,A1]./VSA":RH5$WSFC09##U%.1,CX<N:E
MRL>*,.8AI3$/<20XG7FO5'D?+W[\8?J3[[]</=ZA&T'2F'*-KB7%FH9HP_0*
M&=$]5II*W\_1?V=V)NAD,!X,SXK_K[ "EN"6 \)1(;D!?4@L$#&:+75X%HR'
MP<GPY/<"]"06>H,E15B2%=.4Z%3B"(54L25'X#C* IJ@RY\)NEEA&>-$TAAS
M$Q2Z7.M!H>M:)*^2+5<:_4)^1<8,NO4?/CVCJU0Q3I5"3R)*C2OJ-W3+R0!=
M1A%Z- R%'JFB<DW#7)TB*S""8(>YFFRCF;?2.ID$P6:S&6SG,AH(N81(AN/@
MY8[QKUZ.E'31"#T-0.J ))42DO5:H"U243)8BG7@I':O' 4RNL0X\;'6!6N!
MU=SJSX4!""6;IQKRG-,4(_5&0%#13[=D58\TD@J4\355NAZ<R0 ^&OO#D3\>
M.1*G2U-AC?MS'D@1T2"'%2S,B*JW9$7[6Z1?$ZIJ]\=**G"E$]FP-R I0RM.
M;\;.Y5'P<G_W9$O%*VH%RJ$./CH_/P^LU$$/D-7",N(YO%V%9I"R(WC&S9M.
M*OAP+TDY^$.0"2M05@L]S:"L*%R1<BV;ZC835G.BY9&4@[3(AM1-V2M$%<VA
MEGN$BGX0!T9L.$-3BB>CLBE3; VFK*AJBK+ZB$%0 ?(T_H8W@*"2D8(@> N.
MX/X>#_RL=;ZN932WBS(XVLH=TBP&1,06,3PS;W'16CX+&=_0!4XC<"'E_Z8X
M8@MF7ED:47.85  EL<9R2?4#CJE*,*%'C$$+1FB*.1?:GAUV;?Y)$L87(E_"
M'^8EF9A\/<,^(?/PU^/MH6+;6:X%')8>8M""LL="C5,4T@7CS!H<FM\(^;L3
MTD>6-0WVH?M:4C@1_^07]AG.*@5D&X0Y*')V#CG&)#@B:=2#N/.LF9?_ZS9N
M;S]=YWFD"V0[UL14X<Q3+$XBTU_L?RM[V)DM]EW>OD"X Z@F!S'ZCW0LFY7]
M'<H-.Q5P+SC0<M!108E(J-0,7MM=VPS>+:P(S[N&!10:?:_Q0&UUC6>O'+_'
MJ*#PNT95?5?>/ZAI4.Y8L*IVM"G$)*1&_* E'CO>L[OIG2!6T1&*6?F.YYN_
M_-$)W,@&6Q4Z'[NXL(NOFPN.U]F%^CM+2^..8*Q^Z&"O_C)39U0=H[B%K<\^
MYJLS0#O[94ZQZNO![F[3RKB#FX<.)EO<>-HDO,Q\R(@F\>>FW$:G;W*EGQL]
M?6@:O%JEH,#;I[Y)L!?SO/G!E9%HGVZ3""9N+>3K9UBWVXI(RHJ63SLE;\M,
MS:S8UI\RZ_V<Z+ ACO&VNBA/OJT*8T?('ONVA-TW@U9F'=P\=##9.(P=-7HP
M!04TTFJGHZ\#Y<&SKP-6QYN;8GF0;?+D6TR[5GU2O_LDTB[W#F^?^FP^#*G=
MDU^>;+/]=VIZNM ]_;4N=*V FIF^;_'UB[OT?> -8=LOE@<.Y-\)K =F&(]C
MP9^T(%_5/8WG;D@WM_LO=4+.(ABOS,U<R]2,!.;+V 1NX4R$SW98"%-I??50
M-CQD7UDFH8@QX[>:Q@8&@:5SI9FVWX3_D")-9EZFBP&DP=M_L)28ZT-/]P7_
MIY?3(,O1Q7]02P,$%     @ :%$E6?<$49/8 0  BP,  !4   !L>')P+3(P
M,C0P.#,Q7V-A;"YX;6R-4\UOFS 4OT_:__#&#MND&4/20X*25OGH(5*Z0[).
MO;KF)5@S-K)-(/]];2A9HVU2.2#,^WV]QV-VUY823FBLT&H>I7$2 2JN<Z&.
M\ZBVA%DN1 36,94SJ17.HS/:Z.[VXX?9)T*>EKLMK#6O2U0.5@:9PQP:X0H(
MI0=F'1I"7M&_>I\,1O$X3B:7]TMF/4NKCN.+Z:6R]GJ@#\"#<D=-)G2<T%$R
MNKF ]OK@&F80F.&%<,A=;9B$'*TX*O#!H6\H@\47#NN"F9)5!DNF0E.P.+GX
MHK72U=F(8^'@*_\&P08VY,?]3UC65BBT%O9:UB&*_0X;Q6-82 F[P+"P0XOF
MA/FKG!3J=Q9NS[X_\(-6-FNMF$>%<U5&:=,T<3..M3GZ?I*4/CUL][SPN8A0
M8> <HX$55/[%2Z?3*>VJ _0O9/MLY. QID,<#[<BLYW=5O-NN.^@P7\1X40&
M& FO2#HBXS1N;1[Y:0#T\S!:X@X/ .'A<;>YF,K65#'7)0T%NM)^*7W(CE,8
M/,RC "#ABR237O;S%<B=*[^<5I25]-W1-Y:<25[+KL6M/U_AL76H<LP'E6#^
MGDA.N !,^BL%\N<O>/,8=N]>>>S9[\I!^[T+(?IT,WJU'[<O4$L#!!0    (
M &A1)5F1@IO@B0,  %$0   5    ;'AR<"TR,#(T,#@S,5]D968N>&ULU5?!
M;MLX$+T7V'^8U1ZZ!2I1LAL@,>H63M)#@*1;V-VVMX"F*)LH11HD'3M_7Y(2
M%2N6VR2M=E$?;)E\,_/FS9A#OWZ[+3G<4*69%.,H2]((J" R9V(QCM8ZQIHP
M%H$V6.282T''T2W5T=LW?SQ[_6<<?SF=7L*Y).N2"@-GBF)#<]@PLP2W=86U
MH2J.:_2G*LX(!LDP28^;]5.LK944WL9N9LW.N?4'L@#B/'O3]!@-4S1(!Z\:
MT$P69H,5!:S(DAE*S%IA#CG5;"' $H<JH1%,GA,X7V)5XI6B)18N*9C<F*3Q
M=297MXHME@;^)B_ A8&+^/V[CW"ZUDQ0K6$F^=I1T2_A0I $)IS#U%EHF%)-
MU0W-:W><B:\C]S:W^8$56NC15K-QM#1F-4)HL]DDFV$BU<+FDV;HR]7EC"PM
MKY@))SBA4;!R7KKLLI.3$^1W W0/N9TK'F(,4:#3>+:[N6D,=L%'J-JT4,U&
MVC.[E,37X0$1X"#"?8L#+'9+<3:(AUFRU7EDA0.HI%.2TRDMP'W^.[UH8O*M
M6B5$ELAMH#-IV]=R]"9+18MQY "QJUUZ7'G]JP4RMRO;QIJ5*VYU0#L1;0.%
MH%W0W1@'L@NBN;2.?.BE=:'(>D[CG-E?B?L!1% 'VLVJ\<*$01:*:@SJ=- W
MZR94G,L2LT=2WK?NG:^/$Y>TG+M"/XILV[1OIICSQ_'S!GVS$M),'DLLV/R'
MO4@+O.;FR<T8S'<9VT4FF#O4+NW7%FNZ-53D- ^\G;N'G$*&&0=,JU<&\=V(
MC,$CX0->4#L_"FEGD8M=G7N!$Y>D182[8U>J??UT2%Q3DBSD#<HI\\/1/?@C
ML%*0LFL?=S+71F%B@B>.YY1[_]<64R>!>N<2Y-@1X".>WS5(F]9A],\R+;">
M^YZQ-YT%QJN*+N5&AY4[WO7"]<S8.XFC<\:QUO\4,R/)U\F6Z0[RM<UW3-H9
MW/7B1+5SL<T<_-=]_<3!4?DHE"P?H&_-0#XT&ZERJL;1,/U_2K-+Z+P>/(=J
MTH7MLQC[(_%^)7XL;V<YNA*IZ_#JMZS#=;9'N[=2A('06RU\,G4YCNQC-=M&
M1 ICI\L[[KW;^4@7[N%)Y=J_[;H5>]Z7I12>BKZJ[S9[17#(+F"O\K?O6P>D
M/]Q#0?-#W&NULZ/!KY3S,U8*"_-]*>^#?A<9[_-N)!PV=R74<5ER?W)1ZU_N
MFV]02P,$%     @ :%$E69E=_]K=!@  MC\  !4   !L>')P+3(P,C0P.#,Q
M7VQA8BYX;6S-6UUOVS84?1^P_W#G/FP#)CM.UJX)FA:NFP[!\H4X78L50T!+
MM$U4)@V2CIU_/Y*2'$LB)2=K*+TDMG@N>2[/T:5$2V_>K><QW&$N"*/'G7YW
MKP.8ABPB='K<68H B9"0#@B):(1B1O%QYQZ+SKNW/_[PYJ<@^/+^^@P^L' Y
MQU3"D&,D<00K(F>@F\Z1D)@'08K^.QGG"/:[!]V]UYOC[Y%048R:&-78W[1\
M4/T!FT"H>S:A>Z][!WN]_;W]WS>@$9O(%>(8$ ]G1.)0+CF*(<*"3"DHXI D
M= 2#GT/X,$-\CA8<SQ'52<'@3G8W?0W9XIZ3Z4S"+^&OH(>!T^#BY ;>+P6A
M6 @8L7BIJ8C?X)2&71C$,5SK" '76&!^AZ.TNYC0;T?ZSUCE!VJBJ3A:"W+<
MF4FY..KU5JM5=W7097RJ\MGK][Z<GXW"F>(5$*HG/,2=+$KW8HOK'QX>]DQK
M!BTAUV,>9V,<]#(Z"B[(D3##G;'03.X.8>!$Z&]!!@OTH:"_'QSTNVL1==1L
M "3SP5F,K_$$#.DC>;]0CA)DOH@U)7-LQO'$3B7FO*?C>Q1/M='T,(=ZF/XK
M/<R+]/ 9&N.X QKYZ?K4F=5AKJ\TJ+<CU<=U?H4Y8=$)S4;Y3HD6N]V5_'<=
M?B01ET^:\G*\YP1NF$3QDZAO1WHF?8&?-ML/<;YG655]_+19WHI\!M*R3/C1
M4VN;TU@?.E.?<@3Q6F(:X2BCJ#NHJ+BF?U/83<^;OEF8ZS76M9OQ<MY"]6IZ
M%#CL3ME=+\+$+)OZ0Z _F)35E]LA4Q< @[&0'(4RZ\DD<=RQM/?RA#1NP#-6
M:@FN22Q%]$*F%KB%#.+MDCCA;&X=-,V961IOX_$F/ID4-8259@[$L6!+'N)'
MZ;'-U35#*9]YK!#Z*@K3X-.H\]9@X&N&^O=-[Z&79Y?XA$HB[Z_QE.C1J;Q
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MI.0M=*PW;9>E*1\:&G+GY.2D.D>4)./.%2]J6*_5G.KGRT]#=\IFM,P#%='
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MSPY>CANESM%AJWS8?&I2]WUP1S%'_/:T?W8,S=Y'L'40;9D\G]2F#QZIT47
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MT+ '%N<@@9'-@7 S1T;$ VN5)+P!90(>B9]6OX(?";$XZ"8]?H6D2$\@UNR
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M^S-DVLKI;[X'2E;MG--HYG?^#U!+ P04    " !H4259'R-A@&X:  "/8P
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M6ZA>J^>N@.Z2SB]>?3_=B>SQW!E(2^;0'.P%=<1WYK+&"*QAJQQB <^5N:+
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M"L7EJSE8V,>L8H0S&D.PCS3MD S>$0T>.Z5EH_..N?L7*D0\G$_B#6J2N<S
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M?/GIE6^0)+,V@/D=1!P9*&*4>[EF$CI'CGA?72"/_^G)3"4T8 8K<:GNB2)
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MG&/>E1QSC/VKTNAJ+9HLFILZ.+5,M$:,46RF;EWAJT-6&3$#HC;?S;W-K4;
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M.#,Q+GAS9%!+ 0(4 Q0    ( &A1)5GW!%&3V $  (L#   5
M  "  2$%  !L>')P+3(P,C0P.#,Q7V-A;"YX;6Q02P$"% ,4    " !H4259
MD8*;X(D#  !1$   %0              @ $L!P  ;'AR<"TR,#(T,#@S,5]D
M968N>&UL4$L! A0#%     @ :%$E69E=_]K=!@  MC\  !4
M ( !Z H  &QX<G M,C R-# X,S%?;&%B+GAM;%!+ 0(4 Q0    ( &A1)5E5
MN]C-?@4  +HN   5              "  ?@1  !L>')P+3(P,C0P.#,Q7W!R
M92YX;6Q02P$"% ,4    " !H4259W;&\7A\9   !BP  "P
M@ &I%P  ;'AR<%\X:RYH=&U02P$"% ,4    " !H4259'R-A@&X:  "/8P
M#@              @ 'Q,   ;'AR<%]E>#DY,2YH=&U02P4&      < !P#
) 0  BTL

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>20
<FILENAME>lxrp_8k_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2024"
  xmlns:iso4217="http://www.xbrl.org/2003/iso4217"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:lxrp="http://lxrp.com/20240831"
  xmlns:us-gaap="http://fasb.org/us-gaap/2024"
  xmlns:xbrldi="http://xbrl.org/2006/xbrldi"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="lxrp-20240831.xsd" xlink:type="simple"/>
    <context id="From2024-08-31to2024-08-31">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001348362</identifier>
        </entity>
        <period>
            <startDate>2024-08-31</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-08-31to2024-08-31_lxrp_CommonStocksMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001348362</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lxrp:CommonStocksMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-31</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <context id="From2024-08-31to2024-08-31_lxrp_WarrantsMember">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0001348362</identifier>
            <segment>
                <xbrldi:explicitMember dimension="us-gaap:StatementClassOfStockAxis">lxrp:WarrantsMember</xbrldi:explicitMember>
            </segment>
        </entity>
        <period>
            <startDate>2024-08-31</startDate>
            <endDate>2024-08-31</endDate>
        </period>
    </context>
    <unit id="USD">
        <measure>iso4217:USD</measure>
    </unit>
    <unit id="Shares">
        <measure>shares</measure>
    </unit>
    <unit id="USDPShares">
        <divide>
            <unitNumerator>
                <measure>iso4217:USD</measure>
            </unitNumerator>
            <unitDenominator>
                <measure>shares</measure>
            </unitDenominator>
        </divide>
    </unit>
    <dei:EntityCentralIndexKey contextRef="From2024-08-31to2024-08-31" id="ixv-334">0001348362</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="From2024-08-31to2024-08-31" id="ixv-335">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="From2024-08-31to2024-08-31" id="ixv-371">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="From2024-08-31to2024-08-31" id="ixv-372">2024-08-31</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="From2024-08-31to2024-08-31" id="ixv-373">LEXARIA BIOSCIENCE CORP.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="From2024-08-31to2024-08-31" id="ixv-374">NV</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="From2024-08-31to2024-08-31" id="ixv-375">000-52138</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="From2024-08-31to2024-08-31" id="ixv-376">20-2000871</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="From2024-08-31to2024-08-31" id="ixv-377">100 &#x2013; 740 McCurdy Road</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="From2024-08-31to2024-08-31" id="ixv-378">Kelowna</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="From2024-08-31to2024-08-31" id="ixv-379">BC</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressCountry contextRef="From2024-08-31to2024-08-31" id="ixv-380">CA</dei:EntityAddressCountry>
    <dei:EntityAddressPostalZipCode contextRef="From2024-08-31to2024-08-31" id="ixv-381">V1X 2P7</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="From2024-08-31to2024-08-31" id="ixv-382">250</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="From2024-08-31to2024-08-31" id="ixv-383">765-6424</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="From2024-08-31to2024-08-31" id="ixv-384">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="From2024-08-31to2024-08-31" id="ixv-385">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="From2024-08-31to2024-08-31" id="ixv-386">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="From2024-08-31to2024-08-31" id="ixv-387">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle
      contextRef="From2024-08-31to2024-08-31_lxrp_CommonStocksMember"
      id="aid_1_0">Common Stock, par value $0.001 per share</dei:Security12bTitle>
    <dei:Security12bTitle
      contextRef="From2024-08-31to2024-08-31_lxrp_WarrantsMember"
      id="aid_2_0">Warrants to Purchase Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol
      contextRef="From2024-08-31to2024-08-31_lxrp_CommonStocksMember"
      id="aid_1_1">LEXX</dei:TradingSymbol>
    <dei:TradingSymbol
      contextRef="From2024-08-31to2024-08-31_lxrp_WarrantsMember"
      id="aid_2_1">LEXXW</dei:TradingSymbol>
    <dei:SecurityExchangeName
      contextRef="From2024-08-31to2024-08-31_lxrp_CommonStocksMember"
      id="aid_1_2">NASDAQ</dei:SecurityExchangeName>
    <dei:SecurityExchangeName
      contextRef="From2024-08-31to2024-08-31_lxrp_WarrantsMember"
      id="aid_2_2">NASDAQ</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="From2024-08-31to2024-08-31" id="ixv-394">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
